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Abstract  
Substance abuse and dependence have detrimental effects at both the individual and 
societal levels.  Treatment for such problems has been shown to reduce the negative 
consequences and represents a worthwhile investment.  However, rates of retention in 
substance abuse treatment varies widely.  To date no investigation has examined treatment 
retention across the substance abuse treatment population in Ireland.  This study aims to 
describe the characteristics of service users entering substance abuse treatment 
programmes in the Cork and Kerry region of Ireland, and to identify the significant factors 
associated with treatment retention.  
 
The National Drug Treatment Reporting System (NDTRS) was used to identify those service 
users beginning their first treatment episode between January 1st 2008 and December 31st 
2013.  Logistic regression analysis was used to ascertain significant factors which lead to 
retention in substance abuse treatment.  Models were developed and assessed for 
goodness of fit and discriminatory ability between binary outcomes using a range of metrics.  
An adequate and thorough procedure was followed for examining validity of results.   
 
Results indicated that 47% of service users completed their treatment programme while 
53% dropped out prematurely.  Furthermore, it revealed factors that are related to 
treatment retention including treatment modality, frequency of substance use, education 
level, living status, secondary substance used and the involvement of a concerned family 
member in the treatment episode. Additionally it was highlighted that the factors leading to 
treatment retention were the same for those using alcohol or illicit substances, with the 
exception of higher levels of secondary substance use among illicit substance users.   
Significant differences were also identified between those entering residential treatment 
compared to other forms of treatment.   
 
Results are compared and contrasted with the existing substance abuse treatment 
literature. Study limitations are discussed, along with implications for service providers.  
Future investigations at the individual programme level are recommended to guide the 
monitoring, design, implementation, and evaluation of treatment procedures to enhance 
substance abuse treatment retention. 
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Chapter 1: Introduction 
This chapter provides a background to the research area and places the study to be 
undertaken within the context of the relevant issues.  It begins by defining substance abuse.  
This is followed by an overview of the prevalence of substance abuse in Ireland.   The 
financial cost implications of substance abuse are then outlined followed by a briefing on the 
value of substance abuse treatment and the rates of drop out.  The problem to be address by 
this research is clearly stated and the purpose of the study is outlined.  Finally the specific 
research questions are stated.    
Substance abuse represents a significant public health problem that has generated 
increasing concern in recent years.  The World Health Organisation estimates that the use of 
alcohol results in 3.3 million deaths per year worldwide population (World Health 
Organisation 2015a) .  In addition 15.3 million people are estimated to have drug use 
disorders, with injecting drug use reported in 148 countries, 120 of which report HIV 
infection among the injecting.  Substance abuse refers to “the harmful or hazardous use of 
psychoactive substances, including alcohol and illicit drugs”, (World Health Organisation 
2015b). The use of psychoactive substances have can lead to dependency.  Typical 
manifestations of dependency may include a strong desire to take the drug, difficulties in 
controlling its use, continued usage despite harmful consequences, prioritising drug use to 
the detriment of other activities and obligations.  An increased tolerance may also develop, 
sometimes coexisting with a physical withdrawal state (World Health Organisation 2015b).  
These statistics underlines the importance for individual countries to monitor the severity of 
substance use and take steps to ameliorate associated problems.   
Prevalence of substance abuse in Ireland  
The prevalence of substance abuse in Ireland is measured in the general population through 
the All Ireland Drug Prevalence Survey.  Three measurements are employed for this purpose 
which consists of whether the participant: 1) ever used a drug 2) used a drug in the last 
twelve months and 3) used a drug in the last thirty days.  The most recent survey which took 
place in 2011 revealed that lifetime use of illegal drugs had increased from 24% to 27% since 
2007.  Furthermore a 2007 survey found that 6% of respondents reported that they had 
used an illegal drug in the year prior to the survey.  One in five people had used cannabis, 
while a relatively small proportion of drug users by comparison reported using cocaine (0.5%) or 
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heroin (0.1%), in the previous month. Despite these surveys measuring drug consumption in 
different ways and to various severity levels, they all indicate that drug misuse is prevalent 
in the general population in Ireland, and is not just a problem affecting a confined group of 
society (Connolly & Long 2014).   
 
Cost of substance abuse 
The cost implications of substance abuse span many health and social as well as criminal 
justice systems.   One of the key impacts of illicit drug use on society is the negative health 
consequences experienced by its members placing a substantial financial burden on society.  
In monetary terms this amounts to US$ 200 billion-250 billion which translates to 0.3 to 0.4 
percent of global GDP that would be needed to cover all of the costs related to drug 
treatment worldwide (United Nations Office of Drugs and Crime 2012).  Of course the 
financial impact extends to a society’s lost productivity.  A study in the United States 
suggested that productivity losses were a major source of societal costs and totalled 
US$98.5 billion in 1998 solely due to the lost productivity of those in prison for drug related 
crimes.  This represented over 69% of total costs to society. The costs associated with drug 
related crime are also substantial. The cost of crime in 1998 attributed to illicit drug abuse is 
estimated at US$89 billion (Cartwright 2008).  According to the Irish Department of Health, 
the cost incurred by the Irish society due to alcohol related problems is currently in excess 
of €3.5 billion a year, and this figure relates to alcohol only. Furthermore, alcohol abuse is 
also estimated to be a contributory factor in over 50% of all suicides in Ireland every year. 
The budget for directly drug related public expenditure in 2014 totalled over €240 million in 
Ireland (Connolly & Long 2014).   
 
Value of substance abuse treatment 
Several substance abuse treatment evaluation studies have been carried out over the past 
40 years, of particular note are the Drug Abuse Treatment Outcome Study (DATOS) in the 
United States, National Treatment Outcome Research (NTORS) in the UK and the Research 
Outcome Study in Ireland Evaluating Drug Treatment Effectiveness (ROSIE).  All studies have 
consistently found that treatment ‘works’, indicating that when treatment is provided to 
people requiring services for substance use problems, alcohol and drug use decreases.  In 
addition the crime rate is reduced and other measures of social functioning improve 
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(Prendergast et al. 2002; Hubbard et al. 2003). Furthermore, many of these studies have 
reported a positive relationship linking the length of time spent in treatment and favourable 
outcomes for the individual and society.  Studies which examine the costs associated with 
addiction treatment have shown that the benefits of treatment substantially outweigh the 
costs of investment in drug treatment Cartwright (2000), through a reduction in public 
health costs and criminal activity.  Therefore it makes sense to optimise the benefit derived 
for the individual involved as well as wider society. Retaining people in treatment is a first 
step towards this goal as it is the best means to reduce substance abuse, particularly if the 
planned duration and necessary components of treatment is undertaken.   
 
Substance abuse treatment drop out  
The benefits derived from substance abuse treatment are encouraging, however, there is a 
worrying trend whereby many service users do not remain in treatment long enough to 
realise its benefits. The actual percentage of service users who do not complete substance 
abuse treatment due to choosing to dropout themselves or being forced to leave due to 
non-compliance varies widely across different treatment modalities and treatment models.  
This adds to the difficulty in measuring reasons for drop out.   Lower estimates of the 
dropout rates for residential treatment programs are around 20%, while upper estimates 
can reach 70%.  Non-residential treatment tends to fare much worse and often exhibit 
dropout rates exceeding 60% to 70% (Stark 1992; Wickizer et al. 1994). Overall, 
approximately 50% of clients involved in substance abuse treatment drop out within the 
first month.  Why is it important to be able to predict the potential dropout from substance 
abuse treatment? The question has clinical, organisational and economic significance  (Craig 
1985).  Service users who drop out still use up the scarce resources of treatment providers.  
Furthermore the service user fails to reap of the associated benefits of treatment.  For these 
reasons, treatment retention has emerged as an important outcome measure in the study 
of substance abuse treatment.    
 
Statement of the problem 
Substance abuse and dependence can have damaging effects both at the individual and 
societal level.  Adequate, focused and timely treatment is the best available tool to reduce 
the aforementioned negative individual and societal impacts.  However, the individual 
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requires successful engagement in treatment to realise those benefits.  A ‘successful’, 
treatment episode can be characterised by three distinct phases, each of which presents 
opportunities for either success or failure. First, a client must contact the treatment service. 
Second, after contact has been made and a recommendation for treatment received, the 
client must initiate treatment by beginning to attend treatment sessions. Third, the client 
must stay in treatment long enough to complete the program, including aftercare (Green et 
al. 2002).  The large body of literature on treatment retention clearly indicates that 
unplanned discharge, or 'drop out', is a well-recognised phenomenon of drug treatment, 
with people dropping out before participating fully in elements of treatment that will 
engender change (Gossop et al. 1999). In an attempt to understand the nature of the 
relationship between service user characteristics, treatment modality, treatment type and 
whether the service user completes treatment, a wide range of methodological practices 
have been utilised.   Many of the studies designed to predict who will be retained in 
treatment and who will drop out have shown a great variability among different types of 
treatment programmes and inconsistency among factors which predict treatment drop out 
(Craig 1985).  Therefore, no consistent profile of those likely to complete or dropout has 
been confirmed.  This makes it difficult to generalise findings across countries, treatment 
modalities, treatment types and service users.  
 
Purpose of the Study 
A primary purpose of this study is to develop a profile of service users who enter substance 
abuse treatment services in the Cork and Kerry region of Southern Ireland.  The study will 
also seek to identify the variables which can significantly predict treatment retention.   From 
a service provider perspective, it is difficult for treatment centres to examine treatment 
outcomes without initially identifying who is entering treatment and moreover who is being 
retained in treatment. The identification of variables that positively and negatively relate to 
retention provides an important contribution to the development of procedures, enabling 
treatment providers to detect service users who may be at risk for dropout. Furthermore, 
exploring the factors which may affect treatment retention in this particular population of 
service users offers a baseline in determining if and how such information can be useful to 
the service providers.  This has the potential to inform the development of interventions 
aimed at enhancing treatment retention, which can potentially improve treatment 
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outcomes as the positive relationship between retention and outcomes is well established 
in the literature. From an empirical perspective, this study will allow the comparison of 
results to existing research regarding the characteristics of service users and their 
relationship to treatment retention.  
 
Research Questions  
In light of the problem which has been outlined and the purpose of this investigation, this 
study will address the following research questions: 
 
1) How does the treatment population who completed treatment in residential, non-
residential, low threshold community based and primary care/institutions in Cork and Kerry 
between January 1st 2009 and December 31st 2013 differ from those who dropped out 
prematurely during the same period based on the following variables?: 
Demographic: Gender, Age Group  
Socio-Economic: Education Level, Employment Status, Living Status, Family Involvement  
Programme Level: Treatment Modality, Source of Referral  
Substance: Primary Substance Type, Age of First Use, Frequency of Use, Presence of Second 
Problem Substance, Second Drug Type, Presence of Tertiary Problem Substance  
2) What are the factors significant factors which affect treatment retention?  
 
Study protocols outlining the plan for conducting the study can be viewed in Appendix 1.  
This document was used to explain the purpose and function of the study as well as ethical 
considerations to substance abuse services from which data was obtained.    
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Chapter 2: Literature Review 
This chapter explains the importance of treatment completion and positive treatment 
outcomes. It is organised as follows: first the impact of treatment completion will be 
outlined, followed by a critical review of the literature relating to treatment retention.  The 
focus will be on demographic factors, treatment modality differences, socio-economic and 
individual level factors, and intrinsic factors. The final section will place treatment retention 
in an Irish context.   
Impact of Treatment Completion 
Treatment completion, often confounded with length of stay in treatment, has been linked 
to improved substance use and social outcomes (Greenfield et al. 2004).  There appears to 
be general agreement on the positive individual and societal effects of treatment,  Messina 
et al. (2000) sought to ascertain differences of post treatment drug use, employment and 
criminality between genders.  It was found that treatment completion significantly reduced 
drug use, and criminal activity while increasing employment at 19 month follow up 
interviews.  In fact treatment completion was discovered to be the only significant variable 
for all three outcomes.  The researchers suggest that women required 12 month of 
structured residential treatment combined with aftercare to derive the aforementioned 
benefits; however this claim is not substantiated by the research as there was no 
comparison drawn with shorter durations of stay.  Experiments conducted by Zarkin et al. 
(2002) conflicted to some extent with those of Messina et al. (2000) as both length of stay 
and treatment completion had a negative effect on the number of crimes, but their effects 
were not statistically significant.   These results suggest that the length of stay captures at 
most only a small part of the excluded effect of treatment completion. Although the 
treatment completion findings were mixed, the results indicated that, at least for 
employment, treatment completion plays an important role (Zarkin et al. 2002).   
A meta-analysis conducted by Greenfield et al. (2004) used secondary data sources from 
three large national research projects to examine if longer stays in residential treatment 
were justified in light of the high costs incurred.  Subjects were limited to females, most of 
whom were pregnant or had dependent children.  This work had some limitations, most 
notably, it did not differentiate between treatment sites which included onsite care of 
children and those that did not.  In reality this important factor may impact substantially on 
the time a woman would be able to remain in a residential facility.  Its findings did suggest 
that longer duration of treatment is predictive of post treatment abstinence at 6 and 12 
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month follow up periods, moreover completion of treatment plan goals appeared to be as 
important as length of stay once subjects stayed for a minimum threshold period 
(Greenfield et al. 2004). As the focus was on a very specific cohort and long term effects 
were not tested, the generalisation of these findings to the overall treatment population are 
somewhat questionable. Having said that, findings regarding completion of prescribed 
treatment goals rather than length of stay were echoed by Zarkin et al. (2002).  They 
proposed that completion independent of length of stay is predictive of many positive 
outcomes (Zarkin et al. 2002).  This somewhat agrees with the findings of Greenfield et al. 
(2004) but differs in that Greenfield placed more emphasis on a minimum length of stay of 3 
months as a more valuable component of favourable outcomes.   
The cost of treatment is clearly a central concern of treatment providers, therefore deriving 
the optimal benefit from a single treatment episode should mean the service user is less 
likely to require further interventions.  Luchansky et al. (2000) confirmed that treatment 
completers were less likely to be readmitted during the following year. This finding means 
that those completing treatment are less likely to re-present at a later stage and use up 
valuable resources.   In addition to findings stated previously with regard to treatment 
completers having a higher probability of being employed than non-completers, the 
longitudinal study by  found that, controlling for wages earned before treatment, individuals 
who completed treatment earned more than others (Luchansky et al. 2000).  This was a 
valuable finding which had not been revealed by previous studies, however it neglected to 
incorporate educational achievement which may have occurred in the interim period 
between treatment and follow-up, particularly as the follow-up period was 4 years post 
treatment.  Educational attainment in the interim period would likely have a large influence 
on earnings regardless of treatment completion status.   
Gender Differences in Treatment Outcomes 
Several studies examined mixed gender samples of patients enrolled in substance abuse 
treatment and found predictors of retention and completion specific to men or to women 
(Mertens & Weisner 2000; Green et al. 2002).  However, the ways in which gender affects 
time spent in treatment should be understood as a series of complex relationships between 
gender, the treatment process or modality, and personal and social factors (Stark 1992).  
Women are more likely than men to drop out of substance abuse treatment according to 
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Simpson & Joe (1993) and Stark (1992).   Simpson and Joe (1993) confirmed the previous 
views of Stark (1992).  They attempted to synthesise socio-demographic characteristics with 
psychosocial and treatment process variables and assess the combined effects on treatment 
retention specific to gender.  In addition, the inclusion of a motivation scale added value to 
their analysis as it allowed for a holistic assessment of the subjects.  Greater severity of drug 
problems was the only common predictor for both genders but motivation was higher for 
female than males.  Mertens & Weisner (2000) were in general agreement that both men 
and women who had less severe substance related problems stayed in treatment longer, 
but that other factors differed. Women who were married, unemployed, or had higher 
incomes were more likely to stay in treatment. Among men, employer and family 
suggestions to enter treatment, abstinence goals, and being older predicted treatment 
retention.   In contrast to motivation as a predictor, Mertens & Weisner (2000) proposed 
that external pressures would be more predicative of retention rather than internal 
motivation.  Their finding that employer pressure caused men to remain in treatment while 
spousal pressure was more predictive for women makes sense in light of traditional gender 
roles in society.   
 
Later work by Green et al. (2002) illustrated that external pressures from legal issues led to 
women’s retention in treatment.  This work also further confirmed the link between 
addiction severity and higher rate of drop out as put forth by Mertens & Weisner (2000). A 
potential weakness detected in the data collection and methodology of the Green et al. 
(2002) study was the selection of subjects.   Participants were recruited by counselling staff 
and offered a monetary reward for taking part, furthermore subjects were from a specific 
type of health plan.  This may dilute the strength of findings as the study was not based on a 
random sample and selection bias may have been a factor.  A more robust analysis by Claus 
et al. (2007) sought to ameliorate somewhat the lack of random assignment of subjects to 
specific treatments by the use of propensity scoring which improves the validity of effect 
inferences by from non-experimental comparisons of alternate treatments. It was found 
treatment completion rates for women attending specialised female specific treatment 
were similar to those of women attending mixed gender traditional treatment programmes 
(Claus et al. 2007).  This finding does not support the general consensus which has prevailed 
in the literature which argues for specialised treatment for women.   
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Assessing different treatment modalities by gender highlighted some differences. DATOS 
(Drug Abuse Treatment Outcome Study) researchers found that men were more likely to 
drop out of outpatient drug free programs, while women were more likely to be categorised 
in the low retention group for outpatient methadone treatment (Simpson et al. 1997).   A 
later DATOS article reported greater treatment retention among women than men in non-
residential programs, but no direct gender relationship in long term residential modalities 
(Joe et al. 1999).  This is inconsistent with a UK based study by Beynon et al. (2008) who 
found no difference between men and women in rates of dropout.  However there was no 
distinction between treatment modalities as differences were indicated by Simpson et al. 
(1997).   Despite the large body of literature on gender difference’s which focus on different 
predictors of success specific to gender, the most fundamental question remains answered, 
specifically the causes for under representation of women in treatment.  To be equally 
represented in treatment, the ratio of males to females in treatment should be similar to 
the ratio of males to females in problem drug use, while in Europe it is reported as 4:1 
higher than the ratio between male and female drug users.  To date there are few studies 
that analyse gender differences in the accessibility of treatment services (United Nations 
Office of Drugs and Crime 2012).   
Age Differences in Treatment Outcomes 
Research has generally indicated that age is an important predictor of treatment 
completion.  Older men are more likely than younger men to complete treatment according 
to Green et al. (2002) and have longer overall stays in treatment if aged 40 and older 
(Mertens & Weisner 2000).  However, it is important to note that the mean age of 
participants in both aforementioned studies was approximately 36 for women and 39 for 
men.  This represents a potential limitation as the sample may have been biased towards 
older participants who had longer ‘drug use histories’, and ‘treatment careers’.  Similarly, it 
was reported in a UK study that younger age predicted drop out from treatment and those 
in the older age groups were more likely than their younger counterparts to re-present at 
treatment (Beynon et al. 2006).  The findings by Beynon et al. (2006) are somewhat 
contradictory as they indicate older people are more likely to complete treatment but yet 
also more likely to re-enter treatment at a later stage following successful completion 
indicating potentially higher rates of relapse among this group.  Though this fact was not 
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addressed in the research.  Later Beynon et al. (2008) illustrated that the odds of drop out 
exhibited a significant inverse relationship with age but this effect was mitigated when level 
of social deprivation of subjects was also considered (Beynon et al. 2008).  In addition 
(Wickizer et al. 1994) found that older clients had higher rates of completion in both 
residential and non-residential settings. There was agreement by Woodward et al. (2006) 
who found that probability of treatment completion increased as patient age increased. 
(Woodward et al. 2006), There was a 36 percent increase in the odds of treatment 
completion for every 10 year increase in age.  It is possible that age has a greater influence 
on retention in treatment depending on the level of severity of the problem at entry which 
the aforementioned studies failed to control for.  Stark (1992) discovered through a review 
of several studies from the 1970’s and 1980’s that results for the effect of age on treatment 
completion were largely mixed and inconclusive.  While it could be argued that those 
findings may not be as relevant today, hence more recent studies such as those discussed 
do offer evidence to support the hypothesis and there does appears to be less controversy 
in the findings.     
Treatment Modality & Organisational Factors  
Treatment dropout rates vary widely across modalities and programs. Non-residential 
programmes usually report higher dropout rates, as proportions of more than 70% may be 
observed, but reports on residential dropout rates have ranged from 19% to 67% (Wickizer 
et al. 1994).  However many studies may include clients from different payment structures 
where state funding may or may not be received.  Lack of state funding may be a financial 
barrier to completion.  The relative effectiveness of different types of treatment modality is 
a critical concern for both service providers and policy makers, this is to some extent due to 
the significant differences in costs.  Hser et al. (2004) found that in residential treatment, 
large caseload size decreased chances of retention where in non-residential programs, a 
group therapy focus decreased retention. Given the differential effects of factors in the two 
modalities, research by Ghose (2008) hypothesized that in addition to a direct effect of 
modality on post treatment use, modality will interact with other program factors in 
influencing outcomes.   The results of this study indicated that after controlling for time 
spent in treatment, completing treatment reduced the risk of use after treatment.  The 
strength of the Ghose (2008) study relative to that of Hser et al. (2004) is in its use of 
stratified random sampling procedures which were used to select a nationally 
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representative sample making the findings more generalizable.  Furthermore the use of 
hierarchical regression modelling techniques to account for variance within and between 
facilities ensures estimations and inferences are more accurate, therefore findings are more 
robust.  Woodward et al. (2008) views the probability of treatment retention as a link 
between program structure and operational factors and the individual client demographics.  
The value of this study compared to other lies in the use of a national dataset with detailed 
cost and staffing information.  The findings indicate, treatment completion rates decline as 
the number of groups per counsellor increase. That is, if counsellors have to treat too many 
patients in both group and individual sessions, treatment quality declines and is reflected in 
lower treatment completion rates. These finding built on the earlier work of  Hser et al. 
(1998) where high clinical staff: client ratios and small caseloads were found to be 
significantly associated with favourable treatment outcomes.   
Socio-economic & Individual Level Factors 
Socio-economic factors which may predict treatment retention or drop out have been 
covered extensively in the literature.  As level of education is often used as an indicator of 
socio-economic status, it follows that higher higher educational attainment would lead to 
greater retention.  Knight et al. (2001) noted education level was a significant predictor of 
treatment completion for women in residential treatment settings. Sayre et al. (2002) also 
produced findings which suggest that education level may play an important role in 
treatment completion for non-residential treatment as those completing programmes had 
more years of education than those who dropped out of treatment.    Although the findings 
are in agreement with regard to the positive correlation between education and retention, 
research has neglected to attempt to understand the reasons for this.  However, it is a 
generally accepted notion in public health that higher educational attainment lead to better 
health outcomes overall.  Further indicators of socio economic status include income, Green 
et al. (2002) found that for both males and females, higher levels of financial resources 
predicted retention and completion.  Another finding which has been replicated in many 
studies is the positive link between employment and retention in treatment.  Simpson & Joe 
(1993) found that being unemployed increased the odds of dropping out by 3.1.   As well as 
a measure of socio-economic status, employment can also be viewed as a measure of 
general social functioning, therefore this result is not surprising as employment may signal 
more stable relationships and greater social support.     
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Intrinsic Factors 
Most research on predicting factors associated with treatment retention or drop out has 
focused on demographic or organisational factors.  Deviating from this,  Simpson & Joe 
(1993) examined motivation as a predictor of dropping out of treatment.  Having rigid 
expectations of immediately quitting drugs forever (versus more modest expectations) 
increased the odds of early dropout by 1.9. This study used a scale to measure a service 
users ‘desire for help’, to ascertain level of motivation.  As motivation is a transient state, it 
is therefore questionable as to its efficacy for use in determining accurate prediction of 
treatment retention.  The results suggested that opiate users with more modest and 
possibly more realistic expectations have a more favourable chance of remaining in 
treatment. These results are somewhat limited as only those subjects using opiates were 
included.  It was therefore unsurprising that for this high risk category of drug users, the 
methadone dose they were receiving was identified as one of the most reliable predictors.  
However, a follow up study conducted by Joe et al. (1998) which included alcohol and other 
type of substance users indicated that high levels of pre-treatment motivation was found to 
be the most important predictor of retention and completion. Ball et al. (2006) built further 
on this finding by the additional examination of interpersonal problems, and program 
perception factors.  In agreement with Simpson & Joe (1993) the intrinsic obstacles 
appeared to be more relevant indicators of retention rather than external logistical factors, 
although more difficult to address (Ball et al. 2006).  While the work of Ball et al. (2006) had 
some limitations in that the sample size included only 24 subjects which limits the power of 
the findings substantially, its main value lies its evaluation of service user’s subjective 
reasons for early drop.   
Treatment Outcomes in an Irish Context 
The only major study into treatment outcomes conducted in Ireland was the ROSIE study in 
2009 (Research Outcome Study in Ireland Evaluating Drug Treatment Effectiveness).  This 
national, prospective, longitudinal drug treatment study was undertaken in response to 
acknowledged gaps in the global literature on drug treatment evaluation.  It followed similar 
studies in the USA (DATOS: Drug Abuse Treatment Outcome Study) and (NTORS: National 
Treatment Outcomes Research Study) in the UK in the 1990’s.  The overall outcomes from 
the ROSIE study show drug treatment works and that investment in drug treatment is 
paying dividends. Significant reductions were shown in the key outcome areas of drug use, 
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involvement in crime and injecting drug use. In addition improvements were seen in 
employment and training (Department of Community, Rural and Gaeltacht Affairs 2009).  
Although this was a comprehensive study, it focused exclusively on opiate users, this 
particular group of high risk users may exhibit certain characteristics which are not 
representative of the entire treatment population, and as such its findings may differ for 
other types of substance user.   
 
A follow-up study was conducted using ROSIE data which sought to examine the alcohol 
consumption and treatment outcomes for those who have undergone treatment for opiate 
addiction.  Analysis revealed that those who abstained from alcohol were less likely to be 
using heroin, methadone, cocaine or benzodiazepines than non-abstainers (Stapleton & 
Comiskey 2010).  The most recent Irish study also focused on opiate users, but particularly 
the retention of opiate users in methadone substitution treatment.  This research 
conducted by (Mullen et al. 2012) found that those who attended a specialist addiction 
treatment service site were two times more likely to leave methadone treatment within 12 
months compared with those who attended a general practitioner. The most important 
predictor of retention in treatment was methadone dose, confirming a similar finding by 
Simpson & Joe (1993).  Other indicators of retention included female gender, males were 
found to score lower on the readiness for treatment scale (Mullen et al. 2012).   
 
To date no studies on treatment retention rates with regard to substances other than 
opiates have been conducted in Ireland. The National Drugs Strategy 2009-2016 has 
acknowledged that there has been an improvement in attracting problem drug users into 
services and retaining them there (Department of Community, Rural and Gaeltacht Affairs 
2009). However, no clear target for retention levels or time in treatment has been specified.  
Furthermore, most of the existing evidence regarding factors associated with treatment 
retention is derived primarily within the USA, and to a lesser extent in the UK.  This study 
will attempt to fill this research gap by assessing treatment completion in Irish substance 
abuse services and identifying factors which lead to treatment retention.  In addition 
findings will be compared to that of similar studies in the UK and USA.   
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Chapter 3: Methodology 
This section details the process undertaken in the analysis of the data set.  The overall 
objective to be investigated is to determine the factors which may lead subjects to complete 
treatment and if there is a clear difference between the characteristics of those completing 
and not completing treatment.  Initially a background to the database from which the 
dataset was derived is given, this is followed by an overview of the study population.  A 
description of the variables under consideration is provided.  Finally the stages of the 
preliminary and main analysis are outlined in detail.   
Data 
The data used for this study was obtained from the National Drug Treatment Reporting 
System of the Health Research Board.  The National Drug Treatment Reporting System 
(NDTRS) is an epidemiological database on treated drug and alcohol misuse in Ireland which 
was established in 1990. Treatment is broadly defined as any “activity which aims to 
ameliorate the psychological, medical or social state of individuals who seek help for their 
substance misuse problems”, (Health Research Board 2015).  NDTRS data are reported to 
the European Monitoring Centre for Drugs and Drug Addiction.  All agencies providing 
treatment as defined by the Health Research Board are requested to complete a structured 
questionnaire on each person attending their service.  The structured questionnaire is 
completed by the substance misuse health professional in the presence of the service user.   
Study Population 
For the purposes of this study, agencies providing treatment were limited to those based in 
the Cork and Kerry region of Ireland.  Only data pertaining to those individuals making their 
first ever contact for treatment from January 2009 to December 2013 was included.  The 
initial data was obtained for 5114 client records.  A preliminary examination of the data 
revealed that 423 cases had been previously treated and were removed to ensure that each 
individual only entered the study once.   Treatment completion status was defined in terms 
of the discharge categories which are contained within the questionnaire.  The categories 
included: 1) treatment completed, 2) transferred stable, 3) transferred unstable, 4) client 
did not wish to attend further treatment because he/she considered him/herself to be 
stable, 5) client refused to have further sessions or did not return for subsequent 
appointments, 6) premature exit for non-compliance.  Those cases in relating to 1 and 2 
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were categorised as having completed treatment, while 4 to 6 were categorised as not 
having completed treatment. Following data cleaning, the final study population included 
4,339 cases for further analysis.  Please see appendix 2 for a more detailed explanation of 
observations which have been removed from the dataset.   
The NDTRS database can provide analysis by place of treatment which provides a direct 
indicator of the demand for treatment.  It can also classify the treatment population by 
drug(s) used which allows for a description of patterns of problem substance use, and the 
relationship between substance use and demographic, socio-economic and substance using 
characteristics.  The advantage of using this secondary data source is that it is already in 
existence, however the disadvantage is the data collection and compilation have not been 
done with the current research purpose in mind  (Sorensen et al. 1996).  There are certain 
metrics which would be valuable in this study which are not available from this dataset; 
nevertheless it does offer value in researching the stated problem as an initial evaluation.  In 
addition there were several variables available in the dataset which will not be used for 
analysis, there are two reasons variables were excluded: 1) the number of observations to 
which the variable was applicable were very small relative to the total number of 
observations, or 2) previous literature on this research topic had not yielded any meaningful 
results through inclusion of those variables.  The variables which were selected for this 
analysis included demographic factors such as gender and age range, Socio-economic 
factors include living with whom, employment status, highest level of education achieved at 
the time of treatment and family involvement. Treatment modality and source of referral 
were the only programme level factors available.  Finally substance specific variables 
identifying primary problem substance, frequency of use, age at first use, existence of a 
secondary problem substance, secondary problem substance and the existence of a tertiary 
problem substance were also included.  The original dataset had coded each individual drug 
within a drug class, to simplify analysis and interpretation each drug was categorized 
according to the classification in which it belongs, there were five classifications; alcohol, 
cannabis, hypnotic/benzodiazepine, opiate and stimulant.  Table 1 provides a description of 
the abbreviated variables in the dataset.   
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Table 1: Variable Description 
Variable Remarks Description 
Outcome Binary: 0 No, 1 
Yes 
Treatment completed or not completed 
Gender Factor: male, 
female 
Gender of subject 
Agerange Factor: 4 levels Age range of subjects divided into five levels: under 20, 20 to 
29, 30 to 39, 40 and over 
Living Factor: 5 levels With whom the subject is living divided into five levels: alone, 
alone with children/partner and children (abbreviated to 
alch/ptch), partner or friends (abbreviated to part/fri), parents 
and family (abbreviated to par/fam), other which includes 
homeless, institution and foster care.  
Empstatus Factor: 4 levels Status of employment of the subject divided into four levels: 
employed, unemployed, student and training, other which 
includes housewife/husband, retired and unable to work.   
Educlevel Factor: 5 levels The level of education obtained by the subject at the time of 
treatment.  The levels include current fulltime students, 
primary completed or less, junior certificate (completed at 
approximately age 15), leaving certificate (completed at 
approximately age 18), and third level which includes any post-
secondary education.  
Refsource Factor: 4 levels The source from which referral to treatment was received.  The 
levels include self, family or friends, health professional which 
includes other treatment centres, GP, hospitals, accident and 
emergency staff.  Other professionals include courts, probation 
officers, police and social services.  
Treatmod Factor: 4 levels Setting in which the subject was treated, residential, non-
residential, low threshold community setting, primary care 
provider and institution 
Primdrug Factor: 5 levels The main problem substance for which the subject is attending 
treatment including alcohol, cannabis, 
hypnotic/benzodiazepine, opiate and stimulant 
Primfreq Factor: 4 levels Frequency of use of the main problem substance which is 
either daily, 2 to 6 days per week, once per week or less or no 
use within the month prior to treatment 
Primage Continuous Age of first use of the primary problem substance 
Secondary 
use 
Factor: no, yes Presence of a second problem substance 
Second 
Drug type 
Factor: 7 levels Type of drug if a secondary problem substance exists, the levels 
include alcohol, cannabis, hypnotic/benzodiazepine, opiate, 
stimulant, other (unspecified, “headshop”, solvents, and 
antidepressants).  If no secondary problem substance is 
present this is denoted by no drug.  
Tertiary use Factor: no, yes Presence of a third problem substance 
CP Factor: no, yes Concerned person such as family member or friend involved 
with the subjects treatment 
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Preliminary Analysis 
 
Determining Variable Relevance   
Determining the relative strength of variables in predicting the outcome is a critical phase in 
any model building process.  Therefore two methods were used to assess the strength, and 
the results of each method were compared.  An initial analysis was undertaken using SAS 
(EM) (Statistical Analysis Software (Enterprise Miner)), the variable selection node was used 
to test each variables relation to the target variable.  The R2 criterion was used to score the 
dataset using a goodness-of-fit criterion to evaluate variables. A stepwise regression 
method of selecting variables that stops when the improvement in the value is less than 
0.00050 is undertaken. The method rejects variables whose contribution is less than 0.005. 
The second form of variable relevance evaluation undertaken was using Weight of Evidence 
(WOE), Information Value (IV) and relevant graphs.  WOE measure how much information 
on having completed or not completed treatment is in each variable, while IV is a measure 
of divergence between p(x|treatment completed) and p(x|treatment not completed).  WOE 
and IV were calculated manually using the formulas in Equation 1 and 2.  
Equation 1 
𝑊𝑂𝐸 = 𝑙𝑛 (
% 𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡 𝑛𝑜𝑡 𝑐𝑜𝑚𝑝𝑙𝑒𝑡𝑒𝑑
% 𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡 𝑐𝑜𝑚𝑝𝑙𝑒𝑡𝑒𝑑
) 
Equation 2 
𝐼𝑉 =  ∑(% 𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡 𝑛𝑜𝑡 𝑐𝑜𝑚𝑝𝑙𝑒𝑡𝑒𝑑 − % 𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡 𝑐𝑜𝑚𝑝𝑙𝑒𝑡𝑒𝑑) × 𝑊𝑂𝐸 
 
Missing Value Analysis 
Most studies carried out on epidemiologic data will have some degree of ‘missingness’, in the 
dataset. Missing data can cause a loss of predictive power of any model that is built, as 
valuable information is omitted.   Typical statistical procedures exclude records with missing 
values. Analyses excluding records with missing data can provide biased estimates by using 
less information and by ignoring possible systematic differences between complete and 
incomplete records (Van Der Heijden et al. 2006). Larger standard errors result when less 
information is utilised, and biased estimates will be obtained when the data are not missing 
completely at random (Little 1988). Therefore a rigorous analysis of missing data was carried 
out to assess the extent of the problem details of which are outlined in Appendix 3.   
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Statistical Approach 
 
Selection of the Statistical Approach  
Logistic regression was initially proposed in the 1970’s as an alternative approach to 
overcoming the limitations of ordinary least squares regression in handling dichotomous 
outcomes.  It is a maximum-likelihood method that is widely used in studies involving 
epidemiologic data where often the outcome variable is dichotomous (Peng & So 2002).  As 
the outcome variable in this study is binary, coded as 0 = treatment not completed and, 1 = 
treatment completed, logistic regression is the most suitable statistical modelling approach.  
In addition multivariate logistic regression will be used as there is more than one predictor 
variable.  In logistic regression, instead of predicting the value of a variable Y from a 
predictor variable X, or several predictor variables (Xs), the probability of Y occurring given 
the known values of X is predicted instead.  The logistic regression equation from which the 
probability of Y is predicted is given by:  
𝑃(𝑌) =  
1
1 +  𝑒−(𝛽0+ 𝛽1𝑋1𝑖+ 𝛽2𝑋2𝑖+⋯+𝛽𝑛𝑋𝑛𝑖)
 
The resulting value from the equation varies between 0 and 1.  A value close to 0 means 
that Y is very unlikely to have occurred, while a value close to 1 means that Y is very likely to 
have occurred (Field 2012).  The exponentials of the regression coefficient estimates are 
called odds ratios, which are crucial to the interpretation of logistic regression.  The odds 
ratio is an indicator of the change in odds resulting from a unit change in the predictor.  
Therefore the odds of completing treatment is the probability of completing treatment 
divided by the probability of not completing treatment.  The odds ratio computed by 
dividing the odds after a unit change in the predictor by the original odds is the 
proportionate change in odds (Field 2012).  If the value is greater than 1, it indicates that as 
the predictor increases, the odds of completing treatment increases.  Conversely, a value of 
less than 1 indicates that as the predictor increases, the odds of completing treatment 
decreases.  Odds ratios will be used for interpretation of regression output for the purposes 
of this study.  All regression models and statistical tests were conducted in R Studio.   
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Model Building Process   
Three experimental approaches were taken to model fitting.  Firstly a pairwise bivariate 
analysis between outcome (treatment completed or treatment not completed) on all 
predictor variables was conducted and assessed independently using odds ratios and chi 
squared analysis.  Variables that had a significance level of P < 0.25 in the bivariate analysis 
were then entered into the multivariate logistic regression analysis.  The cut off value of 
0.25 was chosen as more traditional values such as 0.05 can fail in identifying variables 
known to be important (Bursac et al. 2008).  Any value below 0.25 is at least weakly 
associated with the outcome variable.  The Likelihood Ratio Test (LRT) was used to test the 
null hypothesis that the variable under consideration was not associated with treatment 
completion.   
Secondly automated model building techniques were used including all variables.    Multiple 
automated variable selection techniques have been developed based on decision rules and 
algorithms.  Forward, backward and stepwise selection are three such methods which are 
commonly used.  Each procedure decides which variables to keep and which to drop based 
on either the F-statistic or the AIC.  Each of the three techniques in R uses a criterion based 
procedure called the Akaike Information Criterion (AIC).  The AIC is a goodness of fit 
measure that favours smaller residual error in the model but penalises the inclusion of 
further predictors and thus helps to avoid overfitting  (Austin & Tu 2004).  Appendix 4 offers 
a more detailed explanation of stepwise variable selection using the AIC.   
 
Finally an iterative process of model building was used.  Much of the literature on variable 
selection has been critical of automated selection techniques, it has been proposed that all 
model selection techniques are subject to error and no optimal method is known 
(Greenland 1989).     With this in mind and in an attempt to build the most parsimonious 
model, a further strategy was employed whereby all predictors were initially forced into the 
model.  Each predictor was subsequently systematically removed and the effect was 
monitored. Individual parameter estimates were tested by the likelihood ratio test and the 
Wald statistic computed from the ratio of the estimated slope parameter over its standard 
error.  Appendix 5 offers a more detailed explanation of the Likelihood Ratio Test.   
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Testing Overall Model Fit  
Several pseudo R squared measures have been proposed as a descriptive measure of 
goodness of fit for a logistic regression model, however there appears to be no consensus as 
to which is best (Field 2012).  For the purposes of this study Nagelkerke’s R2 is reported as a 
measure of explained variation, which is calculated on the log-likelihood scale (Nagelkerke 
1991).  However, it should be noted for logistic regression models, R2 values tend to be 
much lower than for linear models (Hosmer & Lemeshow 2000).  Hosmer and Lemeshow 
proposed a goodness of fit test that they show, through simulation, is distributed as chi-
square when there is no replication in any of the subpopulations. This test is only available 
for binary response models and was interpreted in this study. (Hosmer & Lemeshow 2000).  
A more detailed explanation of this test is given in Appendix 6.   
Evaluating Predictive Accuracy of Candidate Models 
Final candidate models were evaluated against each other using a range of methods.  Firstly 
a classification based approach was used, this assesses how good the model is at accurately 
separating cases into two bins, one where the event occurs (y=1) and one where it does not 
occur (y=0) (Esarey & Pierce 2011) .  The percent correctly predicted sorts the model 
predictions into two categories, Ŷ=1 and Ŷ=0, on the basis of ?̂?. A threshold of 0.5 was set, 
when ?̂? > 0.5, Ŷ=1, otherwise Ŷ=0.  A misclassification table indicated the number of true 
and false positives and true and false negatives for all models.  A receiver operator curve 
(ROC) was constructed for each final model to illustrate the degree to which the predictions 
agree with the data.  The ROC curve is a plot of sensitivity versus 1 minus specificity.  
Sensitivity denotes the proportion of cases which were correctly classified as treatment 
completed or the fraction of true positives.  Specificity on the other hand denotes the 
proportion of cases correctly classified as treatment not completed or the fraction of false 
positives.  Therefore this curve shows the best model as the one associated with the 
greatest sensitivity and the lowest 1 minus specificity.   
The c-statistic was also calculated, which is equivalent to the area under the receiver 
operating characteristic curve and is a central measure of performance in many studies on 
predicting binary outcomes  (Austin & Steyerberg 2014).  A detailed explanation of the c-
statistic can be viewed in Appendix 7.  A similar measure to the c-statistic which was also 
examined is Somers Dxy rank correlation between predicted probabilities and observed 
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outcomes.  When the value of Dxy = 0, the model is making random predictions.  When Dxy 
= 1, the model discriminates perfectly.   For binary outcomes the AUC and Dxy are related 
by, AUC = Dxy/2 + 0.5. In addition, measures that quantify the overall accuracy of 
predictions were examined. The Brier score, or average prediction error score, provides a 
measure of the agreement between the observed binary outcome and the predicted 
probability of that outcome.  It is calculated as (yi  pi) 2 / n, where y denotes the observed 
outcome and p the prediction for subject i in the data set of n subjects. For adequate 
models the Brier score ranges from 0 (perfect) to 0.25 (worthless) (Steyerberg et al. 2001).  
Being mainly a relative measure, a lower score points to a superior model; the actual value 
of the score seems of limited value  (Rufibach 2010).   
Model Diagnostics  
Residuals were used to: 1) assess observations for which the model is a poor fit, and 2) 
isolate observations which are exerting a high level of influence on the model.  The 
deviance, studentized and standardised residuals were examined to assess 1) and Cook’s 
Distance, Leverage and DFbetas were examined to assess 2).  In addition marginal model 
plots as, a variation of the basic residual plot, were also assessed (Cook & Weisberg 1997).   
Collinearity Diagnostics  
Due to 13 of the 14 variables being categorical, visually checking for correlation patterns 
among predictors was not possible.  Therefore the VIF function in the Car package in R was 
used to test the variance inflation factor.  The results provided are for the Generalised 
Variance Inflation Factor (GVIF).  The GVIF is calculated if any terms in an unweighted linear 
model have more than 1 degrees of freedom.  These are interpretable as the inflation in size 
of the confidence ellipse or ellipsoid for the coefficients of the term in comparison with 
what would be obtained for orthogonal data (Fox & Monette 1992).   
Model Validation  
Validation of any model is an important step in ensuring that the model is likely to perform 
as expected. While the split sampling approach which involves fitting a model to a ‘training’ 
dataset and using the model to test a ‘validation’ dataset is often used to validate predictive 
models, this approach does not make efficient use of all of the information contained in the 
dataset (Austin & Steyerberg 2014).  Split-sample validation results in the validation of a 
model fit to a ‘training’ dataset, but it does not validate the model fit to the complete 
dataset.  Harrell et al. (1996) instead recommend the use of bootstrap resampling as a 
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method of internal validation.  This involves taking a large number of samples with 
replacement from the original sample.  Bootstrapping provides nearly unbiased estimates of 
predictive accuracy that are of relatively low variance (Steyerberg et al. 2001).  In addition 
the entire dataset can be used for model development.  This approach gives optimism 
corrected estimates of the c-statistic along with other model performance statistics. 
Optimism is defined as true performance minus apparent performance, where true 
performance refers to the underlying population of observations, and apparent 
performance refers to the estimated performance in the sample (Steyerberg & Harrell 
2015).  This approach was implemented using the validate function in Harrell’s RMS package 
in R.  
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Chapter 4: Results 
This section provides results of the preliminary and main analysis as set out in chapter 3.  
Descriptive characteristics provide an overview of the sample population according to 
treatment completion status. A graphical profile of each variable and its importance in 
prediction of the outcome variable is provided along with the weights of evidence and 
information value statistics. The results of missing value analysis and approach used to 
address missing values is detailed. Finally, results of the model building process, regression 
diagnostics and model validation are outlined in detail.   
Part 1: Preliminary Analysis  
 
Data Description  
Table 2 presents the descriptive characteristics of the sample by programme level factors.  
Non-residential treatment accounts for 53.5% of those attending treatment for the first 
time, while this group also accounts for 67.5% of those not completing treatment.  The 
largest proportion of cases is self-referred to treatment.  Referrals from health professionals 
only account for 16.2% of the overall referrals.  A larger number are referred from other 
professionals made up of courts, probation, police and social services at 22.7%.   
Table 2: Characteristics of those completing and not completing treatment by programme level 
factors  
Sample characteristics by demographic and socio-economic factors are given in table 3.  
Overall 68.5% were male.  The unemployment rate was 45.1% and 40.1% had ceased school 
attendance at the junior certificate level or lower.  The 20 to 29 age range represents the 
largest proportion of subjects at 30.1% followed by those under 20 years at 26.7%.   
Explanatory Variable Total Completed Not Completed 
N (%) 4339 (100) 2048 (47) 2291 (53) 
Referral Source             
Self 1620 (37.3) 722 (35.3) 898 (39.2) 
Family/friends 1003 (23.1) 577 (28.2) 426 (18.6) 
Health Professional 702 (16.2) 323 (15.8) 379 (16.5) 
Other Professional 985 (22.7) 419 (20.5) 566 (24.7) 
Missing 29 (0.7) 7 (0.3) 22 (1.0) 
Treatment Modality             
Residential 1012 (23.3) 906 (44.2) 106 (4.6) 
Non-residential 2323 (53.5) 776 (37.9) 1547 (67.5) 
Low threshold 824 (19.0) 325 (15.9) 499 (21.8) 
Primary care/Institution 180 (4.1) 41 (2.0) 139 (6.1) 
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The number of subjects who had family or friends involved in their treatment was evenly 
split between those who did and did not.  Furthermore the largest proportion of subjects 
(46.2%) reported living with parents or family while only 12.9% reported living alone.   
Table 3: Characteristics of those completing and not completing treatment by demographic and 
socio-economic factors 
Explanatory Variable Total Completed Not Completed 
N (%) 4339 (100) 2048 (47) 2291 (53) 
Gender             
Male 2973 (68.5) 1339 (65.4) 1634 (71.3) 
Female 1354 (31.2) 703 (34.3) 651 (28.4) 
Missing 12 (0.3) 6 (0.3) 6 (0.3) 
Age Range             
under 20 1157 (26.7) 524 (25.6) 633 (27.6) 
20 to 29 1304 (30.1) 565 (27.6) 739 (32.3) 
30 to 39 808 (18.6) 367 (17.9) 441 (19.2) 
40 and over 1064 (24.5) 590 (28.8) 474 (20.7) 
Missing 6 (0.1) 2 (0.1) 4 (0.2) 
Living             
Alone 558 (12.9) 249 (12.2) 309 (13.5) 
Children/partner 916 (21.1) 469 (22.9) 447 (19.5) 
Partner/Friends 473 (10.9) 206 (10.1) 267 (11.7) 
Parents/Family 2004 (46.2) 955 (46.6) 1049 (45.8) 
Other 351 (8.1) 155 (7.6) 196 (8.6) 
Missing 37 (0.9) 14 (0.7) 23 (1.0) 
Employment Status             
Employed 990 (22.8) 560 (27.3) 430 (18.8) 
Unemployed 1956 (45.1) 812 (39.6) 1144 (49.9) 
Student/training 934 (21.5) 462 (22.6) 472 (20.6) 
Other 414 (9.5) 199 (9.7) 215 (9.4) 
Missing 45 (1.0) 15 (0.7) 30 (1.3) 
Education Level             
Primary or less 544 (12.5) 200 (9.8) 344 (15.0) 
Second Level (Junior) 1198 (27.6) 521 (25.4) 677 (29.6) 
Second Level (Leaving) 1198 (27.6) 633 (30.9) 565 (24.7) 
Third Level 271 (6.2) 171 (8.3) 100 (4.4) 
Current 701 (16.2) 373 (18.2) 328 (14.3) 
Missing 427 (9.8) 150 (7.3) 277 (12.1) 
Family/Friends involved             
Yes 2141 (49.3) 1364 (66.6) 777 (33.9) 
No 2154 (49.6) 662 (32.3) 1492 (65.1) 
Missing 44 (1.0) 22 (1.1) 22 (1.0) 
Table 4 represents the sample by substance specific factors.  Alcohol accounts for 62.4% of 
primary problem substances, with cannabis making up another 23%.  The remaining 14.6% 
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is divided between hypnotics and benzodiazepines, opiates and stimulants.  The percentage 
of those using either daily or two to six days per week amounts to almost 70% of the 
sample.  The mean age for commencing use of the main problem substance was 16 years 
(SD 4.8) across the population.  Almost 43% report the presence of a secondary problem 
substance while 21.7% reported a tertiary problem substance.  Of those with a secondary 
problem substance cannabis and alcohol are the most prevalent with usage at 15.3% and 
13.2% respectively.  Hypnotics and benzodiazepines account for 4.8% or 208 cases where 
there is presence of a secondary problem substance, while the same drug class accounts for 
only 4.1% of primary problem substances.   
Table 4: Characteristics of those completing and not completing treatment by substance use 
factors  
Explanatory Variable Total Completed Not Completed 
N (%) 4339 (100) 2048 (47) 2291 (53) 
Primary Problem Substance             
Alcohol 2708 (62.4) 1351 (66.0) 1357 (59.2) 
Cannabis 999 (23.0) 449 (21.9) 550 (24.0) 
Hypnotic/Benzodiazepine 180 (4.1) 66 (3.2) 114 (5.0) 
Opiates 296 (6.8) 114 (5.6) 182 (7.9) 
Stimulants 156 (3.6) 68 (3.3) 88 (3.8) 
Frequency of Use             
Daily 1225 (28.2) 478 (23.3) 747 (32.6) 
2 to 6 days per week 1783 (41.1) 848 (41.4) 935 (40.8) 
Weekly or less 564 (13.0) 285 (13.9) 269 (11.7) 
No use past month 716 (16.5) 406 (19.8) 310 (13.5) 
Missing 51 (1.2) 21 (1.0) 30 (1.3) 
Mean age of first use: primary 
substance (SD) 16 (4.8) 16 (4.6) 16 (4.7) 
Secondary Drug Use             
Yes 1854 (42.7) 861 (42.0) 993 (43.3) 
No 2485 (57.3) 1187 (58.0) 1298 (56.7) 
Second Drug Type             
Alcohol 574 (13.2) 268 (13.1) 306 (13.4) 
Cannabis 662 (15.3) 313 (15.3) 349 (15.2) 
Hypnotic/Benzo 208 (4.8) 88 (4.3) 120 (5.2) 
Opiate 41 (0.9) 16 (0.8) 25 (1.1) 
Stimulant 279 (6.4) 139 (6.8) 140 (6.1) 
Other 90 (2.1) 37 (1.8) 53 (2.3) 
No Drug 2485 (57.3) 1187 (58.0) 1298 (56.7) 
Tertiary Drug Use             
Yes 943 (21.7) 452 (22.1) 491 (21.4) 
No 3396 (78.3) 1596 (77.9) 1800 (78.6) 
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Variable Relevance  
An initial visual inspection of each attribute’s percentage of treatment completed and 
treatment not completed was undertaken.  If the IV (Information Value) is <0.02, the 
predictor is considered to contain no predictive power.  Those predictors with an IV of 0.02 
to 0.05 are denoted as being weak.  Weak to moderate predictors have and IV between 0.05 
and 0.1.  Moderate predictors are from 0.1 to 0.3 and strong predictors have an IV >0.3.  
Figure 1 shows the proportion of treatment completed and not completed according to the 
presence of a secondary problem substance and the type of substance if present.  Both the 
graphs and the WOE (Weights of Evidence) table show that the numbers completing or not 
completing treatment are very similar for both attribute’s.  The contribution of each class of 
the attribute towards the information value is extremely low implying this variable may be a 
poor predictor of the outcome.  The information value of the secondary use is 0.0007, 
therefore presence of a secondary problem substance appears to be of little relevance to 
classifying treatment outcomes.   The IV of second drug type is 0.0052 also indicating that it 
is a weak predictor.  However WOE for hypnotic/benzodiazepine, opiate and stimulant is 
0.1980, 0.3341 and 0.2472 respectively.  This indicates the variable second drug type may 
be moderately relevant.   
 
Figure 1: Distribution of Secondary Use and Second Drug Type 
Figure 2 represents the distributions of the primary drug of choice and frequency of use.  
The proportion of those completing treatment is higher when alcohol is the main problem 
substance.  All other drugs have lower rates of completion.  The WOE of 
hypnotics/benzodiazepines and opiates are 0.4344 and 0.3556 respectively, which indicated 
that they contain relevant information.  The IV for primdrug overall is 0.0259.  Therefore 
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primary drug of choice appears to be moderately relevant to treatment outcome.  The IV for 
frequency of use is 0.0612.  The WOE for daily use is 0.3343 increasing the relevance of the 
variable, all other rates of use have WOE which are much lower.   
 
Figure 2: Distribution of Primary Drug and Frequency of Use 
 
Figure 3: Distribution of Gender 
The IV for gender is weak at 0.0179, Figure 3 does indicate there is a small difference in 
completion rates for male and female.  Figure 4 illustrates the contribution of education 
level and employment status to treatment completion rates.  Both variables appear to show 
significant differences in each class for percentage of the outcome variable.  Those who are 
educated to primary/less and junior certificate level have WOE of 0.4301 and 0.1497 
respectively.  The overall IV for education level is 0.1019 indicating is a moderate to strong 
predictor.  Employment status is a weaker predictor with an IV of 0.0612.  The WOE for 
unemployed is highest at 0.2306 which is also shown by the graph.   
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Figure 4: Distribution of Education Level and Employment Status 
 
Two of the strongest predictors as demonstrated by IV and WOE graphs in figure 5 are 
family involvement in treatment (CP: Concerned Person) and treatment modality.  Their IV’s 
are 0.4505 and 1.1293 respectively.  This is evidenced in the graphs in Figure 5 as the 
percentage of treatment completed and not completed is very pronounced for all classes 
within the variables.  WOE for those answering no to concerned person involvement is 
0.7004 indicating this has valuable information.  Similarly within the treatment modality 
variable the WOE for the class which identifies those being treated in primary care or 
institutions is 1.1087 and the figure for the class non-residential is 0.5777 showing that they 
are potentially very strong predictors.   
 
Figure 5: Distribution of CP Involvement and Treatment Modality 
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Age range appears to be a weak to moderate predictor, IV is 0.0375, although the WOE 
graph in figure 6 does show some disparity between percentages completing and not 
completing treatment, this is particularly evident in the 20 to 29 and 40 and over class of the 
variable.  Similarly source of referral has a low IV of 0.0587 indicating it holds limited 
important information for predicting the outcome variable. WOE for self-referral is 0.1060 
and 0.1885 for other professional.   
 
Figure 6: Distribution of Age Range and Source of Referral 
The living variable which denotes with whom the subject is living appears to be a weak 
predictor with an IV of 0.0118.  The WOE for the class for living alone is 0.1037 while it is 
0.1472 for living with partner/friend and 0.1225 for living other. 
 
 
Figure 7: Distribution of Living Status and Tertiary Use 
These WOE are low indicating that the variable contains very limited important information 
towards the outcome variable.  The tertiary use variable which identifies those subjects with 
a third problem substance is one of the weakest predictors as illustrated by both the IV and 
the WOE graph.  The overall IV for the variable is 0.0002.  The graph illustrates that there is 
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little difference between those completing and not completing treatment in each of the 
classes.  
 
The distribution of age of first use from Figure 8 shows that the shape of the distributions is 
very similar whether the outcome is treatment completed or not completed. 
 
Figure 8: Distribution of Age of First Use 
Also, the only class within the variable with a high WOE figure is missing which denotes 
when the value was missing from the data set, the WOE is 0.6725. Further, the variable is 
discretized into 10 bins and the information value is 0.0357. Thus, age of first use of the 
problem substance appears to be less important to classify the target variable. 
The variable relevance exploration was undertaken to highlight those variables which have 
the most important information in classifying the target variable, treatment outcome.  Table 
5 shows the predictor variables ranked by level of importance according to their information 
value.  Predictive power is presented in the third column the final column shows the results 
for each variable based on the SAS EM (Statistical Analysis Software (Enterprise Miner)) 
variable selection node analysis.  This analysis is in agreement with the information value for 
the first five predictors which it indicated to include.  It also agrees on the last five 
predictors which have very weak information values and which SAS (EM) indicated should 
be excluded.  Refsource which has a weak to moderate IV was excluded according to SAS 
(EM) variable selection, while agerange which has a lower IV was included.  Also variable 
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selection in SAS (EM) indicated that primdrug should be included while its IV was quite low, 
however as evident by figure 2, certain classes within the primdrug variable have high WOE 
indicating there is somewhat important information within the variable.   
Table 5: Variable Relevance Results
 
 
Missing Value Analysis 
There were 689 cases with at least one missing value accounting for 15.88% of the total 
number of cases.  884 values were missing across the entire sample, representing 1.358% of 
all values.  Of the 15 variables which include the target variable, 9 variables had missing 
values.  This is visually represented by figure 9.  
 
Figure 9: Summary of Missing Values 
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Each variable was subsequently investigated individually to ascertain the percentage missing 
within the variable.  Gender, agerange, living and refsource had less than 1% missing.  
Empstatus, primfreq and cp have less than 2% missing.  Primage and educlevel had the 
highest proportion of missing values with 5.37% and 9.84% missing respectively. While 
35.13% of values missing in educlevel were treatment completers, the balance 64.87% were 
not treatment completers.  These proportions are similar for the primage missing values, 
with 31.33% completing treatment and 68.67% not completing treatment.    A significant 
Little’s Missing Completely At Random test, χ2 = 876.3241, p = <.001, revealed that the data 
were not missing completely at random.  Therefore it is possible that they are cases of 
missing at random or non-ignorable missing as opposed to missing completely at random.   
For this reason the Expectation-Maximization (EM) Algorithm was used to impute values for 
the continuous variable primage.  Missing data were imputed using Missing Values Analysis 
within SPSS 20.0. The EM algorithm involves an interactive procedure in which it uses other 
variables to impute a value (Expectation), then checks whether that is the value most likely 
(Maximization). If not, it re-imputes a more likely value until it reaches the most likely.  This 
method is superior to mean imputation because it preserves the relationship with other 
variables, which is important for building regression models. The missing indicator method 
was also considered which involves creating new binary variables which are coded no for 
not missing and yes for missing values if the value was missing in the original dataset.  The 
original variable would then be imputed with the mode.  This method was dismissed as it 
has been shown to provide an overestimated ROC area. This is because of the inclusion of 
significant but clinically meaningless missing-indicator variables in the final model (Van Der 
Heijden et al. 2006). Categorical variables which had missing values were treated by 
introducing a new value called ‘missing’.  The effect of adding this new value is that if the 
fact that the value is missing contains important information about the value itself (non-
ignorable missing), the introduction of the new ‘missing’, value will capture this.  If the 
values are in fact missing completely at random, the cases with this value will not exhibit 
any deviation from those which do not have the ‘missing’, value (Gries & Schneider 2010) 
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Part 2: Regression Analysis  
 
Bivariate Analysis 
Bivariate analyses showed that treatment completion was significantly associated with ten 
variables denoted in table 6. Firstly, being male reduces the odds of completing treatment 
by 24% (odds ratio 0.76, 95% confidence interval 0.67 to 0.86) compared to being female 
(reference group). Secondly, those in the age group 40 and over are significantly more likely 
to complete treatment compared to those in the age groups under 20, 30 to 39 and 20 to 
29(the reference group) (odds ratio 1.63, 95% confidence interval 1.38, 1.92). The odds of 
treatment completion were significantly higher among those educated to third level (third 
level refers post-secondary education e.g. university).  With all other predictors the same a 
service user educated to third level has odds of completing treatment 1.5 times higher, with 
95% confidence interval 1.43 to 1.90.   Living alone, compared to living with a partner and 
children significantly reduces the odds of treatment completion (odds ratio 0.77, confidence 
interval 0.62, 0.95).  Being unemployed or a student significantly reduces the odds of 
completing treatment by 45% (odds ratio 0.55, confidence interval 0.47, 0.64) and 25% 
(odds ratio 0.75, confidence interval 0.63, 0.90) respectively compared to being employed.  
For those service users who attended treatment at residential treatment centres the odds 
of completing treatment were significantly greater than the odds of completion for those 
attending non-residential treatment. They have an odds ratio of completion 13 times higher, 
with 95% confidence interval 10.31 to 16.83.   
 
With respect to the primary substance profile, the odds of completing treatment was 
significantly lower for individuals who were hypnotic/benzodiazepine users (odds ratio 0.82, 
95% confidence interval 0.71 to 0.95), and for opiate users (odds ratio 0.63, 95% confidence 
interval 0.49 to 0.80). Those whose frequency of use is weekly or less and those who hadn’t 
used for one month prior to treatment have a higher odds of completing treatment and are 
significantly more likely to complete treatment compared to those using 2 to 6 days per 
week.  Those who use daily are less likely to complete treatment (odds ratio 0.71, 95% 
confidence interval 0.61 to 0.82).  Finally, the odds of treatment completion varied 
according to the involvement of a concerned family member or friend.   Compared with a 
service user who did not have a concerned person involved with their treatment, those who 
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did had odds of completing treatment 1.76 times higher, with 95% confidence interval 0.96 
to 3.2. 
Table 6: Factors Affecting Substance Abuse Treatment Retention, Bivariate Analyses 
 
Parameter Estimate
Standard 
Error
Wald chi-
square Pr>ChiSq
Odds 
ratio  (Conf. Int)
Gender Male -0.276 0.0657 -4.2 < 0.001 0.76 (0.67, 0.86)
Missing -0.0768 0.5799 -0.13 0.8946 0.93 (0.29, 2.97)
Female reference
Age Range under 20 0.0795 0.0813 0.98 0.3282 1.08 (0.92, 1.27)
30 to 39 0.0848 0.0901 0.94 0.3466 1.09 (0.91, 1.3)
40 and over 0.4874 0.0832 5.86 <  0.001 1.63 (1.38, 1.92)
Missing -0.4247 0.8675 -0.49 0.6244 0.65 (0.09, 3.36)
20 to 29 reference
Living Alone -0.2639 0.1078 -2.45 0.0144 0.77 (0.62, 0.95)
Partner/Friends -0.3074 0.1139 -2.7 0.0069 0.74 (0.59, 0.92)
Parents/Family -0.1419 0.0798 -1.78 0.0754 0.87 (0.74, 1.01)
Other -0.2827 0.1262 -2.24 0.0251 0.75 (0.59, 0.96)
Missing -0.5445 0.3453 -1.58 0.1148 0.58 (0.29, 1.13)
Children/partner reference
Employment Status Unemployed -0.6069 0.0788 -7.7 < 0.001 0.55 (0.47, 0.64)
Student/training -0.2856 0.0916 -3.12 0.0018 0.75 (0.63, 0.9)
Other -0.3415 0.1174 -2.91 0.0036 0.71 (0.56, 0.89)
Missing -0.9573 0.3227 -2.97 0.003 0.38 (0.2, 0.71)
Employed reference
Education Level Primary or less -0.6709 0.1168 -5.75 < 0.001 0.51 (0.41, 0.64)
Second Level (J) -0.3905 0.0955 -4.09 < 0.001 0.68 (0.56, 0.82)
Second Level (L) -0.0149 0.0953 -0.16 0.8756 0.99 (0.82, 1.19)
Third Level 0.4079 0.1469 2.78 0.0055 1.5 (1.13, 2.01)
Missing -0.7419 0.1265 -5.86 < 0.001 0.48 (0.37, 0.61)
Current reference
Referral Source Self -0.5215 0.0811 -6.43 < 0.001 0.59 (0.51, 0.7)
Health Prof -0.4633 0.0991 -4.68 < 0.001 0.63 (0.52, 0.76)
Other Prof -0.6041 0.0907 -6.66 < 0.001 0.55 (0.46, 0.65)
Missing -1.4485 0.4386 -3.3 0.001 0.23 (0.09, 0.53)
Family/friends reference
Treatment Modality Residential 2.5744 0.125 20.6 < 0.001 13.12 (10.31, 16.83)
Non-residential -0.2611 0.0838 -3.12 0.0018 0.77 (0.65, 0.91)
PrimC/Institution -0.7921 0.1915 -4.14 < 0.001 0.45 (0.31, 0.65)
Low threshold reference
Primary Substance Cannabis -0.1985 0.0743 -2.67 0.0076 0.82 (0.71, 0.95)
Hypno/Benzo -0.5421 0.1594 -3.4 0.0007 0.58 (0.42, 0.79)
Opiate -0.4634 0.1255 -3.69 0.0002 0.63 (0.49, 0.8)
Stimulant -0.2534 0.166 -1.53 0.1268 0.78 (0.56, 1.07)
Alcohol reference
Frequency of Use Daily -0.3488 0.0754 -4.63 < 0.001 0.71 (0.61, 0.82)
Weekly or less 0.1899 0.0967 1.96 0.0496 1.21 (1, 1.46)
No use past month 0.3674 0.0891 4.12 < 0.001 1.44 (1.21, 1.72)
Missing -0.259 0.2884 -0.9 0.3692 0.77 (0.43, 1.35)
2 to 6 days p/w reference
CP Involved Yes 0.5627 0.3048 1.85 0.0649 1.76 (0.96, 3.2)
No -0.8126 0.3051 -2.66 0.0077 0.44 (0.24, 0.81)
Missing reference
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Secondary drug use, second drug type, tertiary drug use and age of first use were not 
significantly associated with treatment outcome in bivariate analysis. 
 
Multivariate Stepwise Analysis 
Automated variable selection using forward, backward and stepwise methods was in 
agreement on the optimal model for the data.  Logistic regression analysis results in table 7 
show that treatment completion continued to be significantly more likely among those 
attending residential treatment centres compared to those attending other types of 
treatment  in multivariate analyses (adjusted odds ratio 12.06, 95% confidence interval 9.12 
to 16.05).  Treatment completion was significantly more likely among less regular users 
compared to those using weekly or less (Adjusted odds ratio 1.96, 95% confidence interval 
1.59 to 2.24).   Those having an education level of primary or less continued to be 
significantly less likely to complete treatment (adjusted odds ratio 0.44, 95% confidence 
interval 0.3 to 0.64).  In addition being unemployed also continued to be significantly 
associated with treatment drop out (adjusted odds ratio 0.65, 95% confidence interval 0.53 
to 0.79).  Those who did not have a family member or friend involved in their treatment 
continued to be less likely to complete treatment (adjusted odds ratio 0.5, 95% confidence 
interval 0.26 to 0.96).  Other explanatory variables (primary substance, referral source, age 
range and gender) were not significantly associated with treatment outcome following 
simultaneous adjustments for other variables. 
Iterative Model Building  
The process of building the model step by step initially including all predictors and then 
systematically removing one at a time yielded some interesting results.  The variable second 
drug type was not significant in a bivariate analysis indicating that it is not related to the 
treatment outcome.  However it was found that this variable became significant when the 
variable treatment modality was added to the model.  This suggests that there may be an 
interaction effect between the two variables.  Some additional investigation showed that of 
those cases where alcohol was the primary problem substance, only 23% indicated a second 
problem substance.  Conversely of those cases whose primary problem substance was an 
illicit drug, 63% indicated a second problem substance. The data was therefore subdivided 
into cases whereby alcohol was the primary problem substance and illicit drugs were the 
primary problem substance.  
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            Table 7: Factors Affecting Substance Abuse Treatment Retention, Multivariate Analysis 
 
Logistic regression was conducted on each of the two datasets.  All variables which were 
significant in the full dataset were also significant in the two sub datasets.  The only 
difference was that second drug type was significant for illicit drug cases but not for alcohol 
cases.  All other predictors which were shown to contribute to the model using stepwise 
selection were shown to be relevant through the iterative process.   
Collinearity 
The generalised variance inflation factor (GVIF) showed that employment status and 
education level had the highest GVIF at 5.656 and 4.494 respectively. It is possible that 
these two variables are correlated as the possibility of being employed is likely higher for 
Parameter Odds ratio  (Conf. Int)
Intercept 1.45 (0.68, 3.11)
Living Alone 0.86 (0.66, 1.13)
Partner/Friends 0.88 (0.66, 1.15)
Parents/Family 1.01 (0.82, 1.26)
Other 2.04 (1.51, 2.76)
Missing 1.03 (0.48, 2.14)
Children/partner reference
Employment Status Unemployed 0.65 (0.53, 0.79)
Student/training 0.91 (0.65, 1.29)
Other 0.94 (0.7, 1.25)
Missing 0.86 (0.42, 1.72)
Employed reference
Education Level Primary or less 0.44 (0.3, 0.64)
Second Level (Junior) 0.66 (0.47, 0.92)
Second Level (Leaving) 0.69 (0.48, 0.98)
Third Level 0.95 (0.6, 1.5)
Missing 0.61 (0.41, 0.91)
Current reference
Treatment Modality Residential 12.06 (9.12, 16.05)
Non-residential 0.8 (0.66, 0.96)
Primary care/Institution 0.45 (0.29, 0.69)
Low threshold reference
Frequency of Use Daily 0.91 (0.76, 1.08)
Weekly or less 1.37 (1.1, 1.71)
No use past month 1.96 (1.59, 2.41)
Missing 0.74 (0.37, 1.44)
2 to 6 days per week reference
CP Involved Yes 0.93 (0.49, 1.8)
No 0.5 (0.26, 0.96)
Missing reference
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those with higher levels of education.  Both variables are indicators of socio-economic 
status, therefore including both in the model may be redundant as they don’t contribute 
independent pieces of information.    
Final Candidate Models 
Three models were selected as the final candidate models.  Model 1 was derived from using 
bivariate analysis and subsequently retaining predictors which were still significant in 
multivariate analysis.  The variables including; Living, Educlevel, Empstatus, Treatmod, 
Primfreq and CP.  Model 2 was derived from the iterative model building process, whereby 
the variable second drug type was included even though it was not shown to be related to 
the outcome variable in bivariate analysis.  The variables include; Living, Educlevel, 
Empstatus, Treatmod, Primfreq, CP and Seconddrugtype.  Model 3 was derived from model 
2 but with the exclusion of the employment status variable due to its high GVIF value.  The 
variables include; Living, Educlevel, Treatmod, Primfreq, CP and Seconddrugtype.   
Testing Overall Model Fit 
Table 8 shows the results of goodness of fit tests for each of the three final models.  The 
Hosmer Lemeshow tests the hypothesis that there is no significant difference between the 
observed and predicted values.  The P-value for model 1 and model 2 and model 3 of 
0.3835, 0.4355 and 0.5442 respectively.  Therefore the null hypothesis cannot be rejected.  
The large p-values signify that there is no significant difference between the observed and 
predicted values of the outcome of any of the models.  This indicates that all three models 
fit quite reasonably.  The R2 values, although quite low do offer a comparison between the 
three models, model 2 has the highest R2 value at 0.360.   
Table 8: Goodness of Fit Statistics 
Overall Model Fit: Goodness of Fit Statistics   
Tests  Model 1 Model 2 Model 3 
Inferential Test       
Hosmer Lemeshow p = 0.3835 p = 0.4355 p = 0.5442 
Descriptive Measures       
Nagelkerke R2 Index 0.356 0.360 0.356 
 
Evaluation of Final Models 
Table 9 depicts assessments of the predictive power of the models.  The misclassification 
rate is 27% for model 2 and model 3, the value is 28% for model 1.  This indicates that both 
model 2 and model 3 are slightly better as classifying the outcome correctly.  Somers Dxy 
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rank correlation indicates that the predictive ability of all three models is above the 0.5 
level.  The statistic for model 2 is slightly higher at 0.587 compared to 0.579 for model 1 and 
0.583 for model 3.  The Brier Score is similar for all three models with models 2 and 3 
performing slightly better at 0.180, which is closer to zero than 0.181 indicating model 2 and 
model 3 are superior in terms of calibration, the statistical consistency between the 
predicted probability and the observations.   
Table 9: Predictive Power Tests 
 
 
 
Figure 10: Receiver Operator Curve Model 1 and Model 2 
The area under the receiver operator curve given by the c-statistic indicates that model 2 
and model 3 are slightly better at classifying the outcome variable as the c-statistic is 79.4 
and 79.2 respectively compared to 79 for model 1.  The Receiver Operator Curve (ROC) for 
each model illustrated in figure 10 and figure 11 further demonstrate this along with 95% 
confidence intervals for the c-statistic.  
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Figure 11: Receiver Operator Curve Model 3 
Selection of Optimal Model 
The analysis thus far has shown that all three candidate models perform reasonably well on 
the metrics which were tested.  It does appear that model 2 and model 3 consistently 
outperformed model 1.  A final measure to evaluate the models is to plot the conditional 
distribution of the response given the fit of the model.  This plot shows that if the lines are 
similar, the model is reproducing the data in that direction, if they differ it is an indication 
that the model may be miss-specified.   
 
Figure 12: Marginal Model Plot - Model 1 
Figure 12 shows the outcome plotted against the linear predictor.  The real data is 
represented by the solid blue line and the model is represented by the dashed red line.  .  
The data dips below the solid line from about 0.1 to 0.2, it then goes above the solid line 
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from 0.5 to 0.6.  There is only a slight deviation between the blue line representing the data 
and the red line representing the model meaning that the model relating the parameter to 
the predictors has a reasonably close resemblance to the true relationship.   
 
Figure 13: Marginal Model Plot - Model 2 
Similarly Figure 13 shows this relationship for model 2.   We can see that there is an 
improvement on the fit of model 1.  The lines representing the model and the data are more 
closely aligned with less visible deviation between the data and the model.  Finally the 
marginal model plot for model 3 was examined and is shown in figure 14.  It is evident that 
the model fits the data perfectly as both lines are exactly aligned to one another.  The red 
line representing the model is also more visible coming through the blue line.  There does 
not appear to be any deviation indicating that the model closely resembles the true 
relationship.  Model 3 performed well in terms of goodness of fit statistics and predictive 
power.  Although it was slightly lower than model 2 on several of the metrics, figure 14 
illustrates that it is an excellent fit to the data.  Furthermore collinearity diagnostics show 
that GVIF values are all close to 1, indicating that there is no collinearity between variables.  
The inclusion of the second drug type predictor in both Model 2 and Model 3 has shown to 
improve performance in both models over Model 1.  For this particular dataset which 
includes both alcohol and illicit drug cases, the inclusion of second drug type produces 
significantly stronger models.  While the GVIF for employment status is not exceptionally 
high at 5.656, and moreover its inclusion in Model 1 and 2 did not have a substantial effect 
on standard errors, the marginal model plot does show a slightly better fit to the data with 
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its exclusion from Model 3.  Therefore in the interests of building the most parsimonious 
model to explain the outcome variable, Model 3 appears to be the best choice.   
 
Figure 14: Marginal Model Plot - Model 3 
Regression Diagnostics 
Residuals  
As non-constant variance is always present in the logistic regression model, response 
outliers are difficult to diagnose.  Therefore the residual analysis focused on the detection of 
model inadequacy in the covariate space only.  This suggests that if the model is correct and 
there is no significant incorporation of outliers, a LOWESS smooth of the plot of residuals 
against the linear predictor should result in approximately a horizontal line with zero 
intercept.  Any significant departure from this suggests that the model may be inadequate 
and potential outliers may be having a dramatic effect on the fit of the model (Sarkar et al. 
2011).  The LOWESS smooth of the deviance residuals plotted against the linear predictor 
for model is shown in figure 15.  The LOWESS smooth approximates a line slightly away from 
zero, a LOWESS span of 0.8 was used.  This graph indicates the potential presence of outliers 
and influential observations, although it is not a useful measure to detect the specific 
observations.   Furthermore it is evident that there are observations lying outside of 2 in 
absolute value.   
Leverage Values, Outliers and Influential Observations  
Table 10 displays cases which had the highest values of Studentized Residuals, Leverage 
values and Cook’s Distance.  There is no value of Cook’s Distance which is greater than 1. In 
addition all values of DFbeta were examined, there were no values greater than 0.4, only 3 
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values were greater than 0.3.  Values of Dfbetas less than one are generally considered 
acceptable and do not signify highly influential observations in the data. 
 
Figure 15: Deviance Residuals versus Linear Predictor 
There are no observations with residual values greater than 2.5 in absolute value; however 
those which are close to 2.5 were examined.    Three of the observations have leverage 
values greater than 0.05 which were also investigated.  Figure 15 shows Cook’s distance 
plotted against the leverage values.  The highest concentration of cases lies in the lower left 
quadrant of the graph, showing that the majority of cases are low on both parameters.  The 
observations close to or outside of 0.06 on leverage and outside of 0.006 on Cook’s distance 
are evident in the graph.   
 
All nine cases were removed individually and the effect on parameter estimates was 
examined.  The removal of each case individually did not alter the results substantially.  
Therefore all 9 cases were removed and systematically added back into the dataset and the 
effect examined as each new case was added back in.  It was found that the removal of case 
735 had a substantial effect by changing the sign of the coefficient on the variable CP 
(concerned person involved in treatment).  This categorical variable has 3 levels; yes, no and 
missing.  The yes level changed from a negative to a positive coefficient.  The original data 
for each case was further examined.  Case 735 had 4 missing values case 807 had 3 missing 
values which may account for their significant influence on the coefficients.  Case 490, 605, 
780, 1313, 2036 and 4224 and 4322 did not have more than one missing value. 
 
Lancaster University | Norma Madden 
 
43 
 
Table 10: Cases With Highest Values of Residuals, Leverage and Cook’s Distance 
 
All cases which were removed exhibited a unique pattern of characteristics of the outcome 
and predictor variables, indicating that the model was not fitting them adequately.   
 
Figure 16: Cook's Distance versus Leverage Values 
The most notable change to the coefficients with the removal of the nine cases was on the 
CP variable.  The coefficient for the yes level within the variable changed from -0.09475 to 
+0.01059.  The “no”, level of the variable also changed from significant to insignificant.  The 
coefficients for the living variable (level: missing) also changed from a positive to a negative 
sign, +0.04131 to -0.0040.  The coefficient for level “parents/family”, within the living 
variable increased by approximately 20%.  The most marked effect on the education level 
coefficients was on third level education, with a change from -0.0583 to -0.01059.  Within 
the second drug type variable, “opiate”, decreased by about 30%.  This level of the variable 
also became more significant than it had been previously.  The treatment modality variable 
saw a decrease in the primary care/institution coefficient, this level of the variable became 
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slightly less significant.  The significance level of all other variables remained the same as 
before the influential cases were deleted.  Figure 17 shows the Cook’s distance plotted 
against leverage values following removal of the nine influential cases.  It can be seen that 
no observations are lying outside of or close to 0.06 on leverage.   
 
Figure 17: Cook's Distance versus Leverage Values (Influential Observations Removed) 
Logistic regression was conducted on the new dataset excluding the nine influential cases.  
The model performed slightly better on several of the performance metrics.  The R2 value 
increased to 0.361.  The c-statistic increased to 0.794 from 0.792.  The value for Somers Dxy 
is 0.588 increased from 0.583.  The Brier score reduced from 0.180 to 0.179.  The 
misclassification rate of the model is remained at 27%.  Therefore removal of the influential 
cases had a positive impact on the overall fit of the model.  Results for this model 3 can be 
viewed in Appendix 8, while Appendix 9 shows results with influential cases removed.   
Final Model Validation 
Bootstrap resampling validation using the ‘boot’, method in the RMS package within R 
Studio was used instead the split-sample approach in order to maximise the sample size for 
model development, 200 bootstrap repetitions were taken (Steyerberg et al. 2001).  Table 
11 summarises the estimates of four common model performance statistics: the area under 
the receiver operating characteristic curve (AUC), the Somer’s Statistic (Dxy), Nagelkerke’s 
R2, and the Brier Score.  The optimism corrected estimates on all parameters indicate that 
the model still performs well under internal validation procedures.   A logistic model with an 
optimism corrected AUC of greater than 0.7873 has a reasonable capability of discriminating 
between the two states of the binary outcome variable. 
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Table 11: Optimism Corrected Model Validation Statistics Using Bootstrap Resampling  
Estimate Optimistic Estimate Optimism Correction 
Optimism Corrected 
Estimate 
AUC 0.794 0.0067 0.7873 
Dxy 0.588 0.0130 0.5746 
Brier Score 0.1795 -0.0024 0.1819 
R-squared 0.361 0.0109 0.3499 
 
Further Analysis 
The results show that treatment modality is the strongest predictor of treatment retention, 
to investigate this finding further, a logistic regression analysis was performed to ascertain if 
there were differences between those entering residential treatment compared to other 
types of treatment.  The outcome variable treatment modality was set to 1 = residential, or 
0 = other forms of treatment.  The results indicate that those aged 40 and over have an odds 
ratio of entering residential treatment 2.61 times higher with a 95% confidence interval 
between 2.1 and 3.24.  Those educated to third level have an odds ratio of 3.08 of entering 
residential treatment with a confidence interval between 1.94 and 4.99.   Those educated to 
leaving certificate level having an odds of 2.5 times, with a confidence interval between 1.72 
and 3.92.  A significant negative association was revealed between those using daily and the 
outcome variable, (odds ratio 0.69, confidence interval 0.56 to 0.85).  Poly drug use was also 
shown to be significantly associated with attending residential treatment, those with a 
second problem substance have an odds ratio of 1.65, with a confidence interval between 
1.32 and 2.07, while those with three problem substance have an odds ratio of entering 
residential treatment of 2.36, with a confidence interval between 1.84 and 3.03.  All primary 
drugs were significantly negatively associated with the outcome variable.  The Likelihood 
Ratio Test resulted in chi-squared 856.53 on 19 degrees of freedom, p <0.001.  The c-
statistic is 0.785 demonstrating that the model has achieves reasonable discrimination 
between the outcome, those entering residential treatment and those entering other forms 
of treatment.   A brier score of 0.146 shows that the model provides a good measure of 
agreement between observed and predicted probabilities as the value is close to zero.  The 
Hosmer Lemeshow goodness of fit test indicated that this model is a good fit, p-value 
0.3148.  Therefore the null hypothesis that there is no significant differences between the 
observed and predicted values cannot be rejected, indicating that the model is a good fit to 
the data.  Please see Appendix 10 for detailed results.   
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Chapter 5: Discussion, Limitations & Conclusion 
This section discusses the implications of results presented in chapter 4.  It also highlights the 
strengths and shortcomings of the research undertaken.  Recommendations are put forward 
for service providers and suggested orientation for further research which build on the 
findings of this study is outlined.  Finally a conclusion is given.   
Previous research has demonstrated that retention in substance abuse treatment is 
positively associated with favourable post treatment outcomes such as, reduced substance 
use, reduced crime levels, and improvement in social functioning.   Rates of retention can be 
improved by better understanding factors associated with premature drop out. The aims of 
the present study were to identify and assess factors associated with substance abuse 
treatment retention. While a number of factors associated with treatment retention are 
identified, results also highlight that drop out and retention is an index that captures the 
complexity of many factors.  Results show that overall in the Cork and Kerry region of 
southern Ireland, retention rates of 47% were achieved.  This is largely in line with previous 
studies which found retention rates of approximately 50% (Stark 1992).   
Findings were contrasted with previous research, although previous studies may have used 
differing interpretations and methods to measure variables, it is nevertheless a worthwhile 
comparison.  With respect to demographic characteristics, studies in the USA have reported 
longer durations of treatment for older drug users and higher retention rates (Wickizer et al. 
1994).    Evidence from a UK-based retrospective cohort study showed that younger drug 
users (aged 10 to 19 years) were more likely to drop out than their older counterparts 
(Beynon et al. 2006). Here, bivariate analysis showed that the odds of retention was 
significantly higher for those aged 40 and over. However, the multivariate analysis showed 
that age was not significantly associated with treatment retention once other covariates 
were simultaneously adjusted for.  Further analysis to ascertain if there were significant 
differences in groups entering residential treatment as opposed to those entering other 
treatment modalities showed that those aged 40 or over were more likely to enter 
residential treatment and therefore more likely to be among those completing treatment as 
completion rates for this group were close to 90%.  With regard to gender differences in 
retention rates, studies have shown largely mixed results, some highlight significant 
differences while others fail to find any difference.  Bivariate analysis in this study suggested 
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males had a higher odds ratio of drop out than females, this result was not significant when 
other variables entered the model.  The ratio of males to females in this study was 2:1, this 
is somewhat encouraging as European wide ratios for males and females entering treatment 
are reported as 4:1 (United Nations Office of Drugs and Crime 2012).   
 
There is a large body of evidence which shows the relationship between socio-economic 
status and health.  Over 45% of the study population were unemployed and over 40% were 
educated to junior certificate level which equates to leaving school at approximately aged 
15.  Low employment levels and low educational attainment generally coexist with poorer 
health outcomes and poorer substance abuse treatment retention and outcomes 
specifically (Sayre et al. 2002; Knight et al. 2001; Simpson & Joe 1993).  Of those employed 
57% completed treatment while only 41% of those unemployed completed treatment.  It 
was demonstrated that being unemployed was negatively associated with treatment 
completion, providing further support for previous findings which have shown a positive 
correlation between employment and treatment completion.  It is also worth noting that 
this data relates to a period from 2008 to 2013 when unemployment rates in Ireland 
increased from 5% to almost 15%, therefore this finding may not hold if tested on data from 
a different period.   
 
There is some evidence in the literature which indicates that social support for the person 
undergoing treatment is an important factor in determining treatment retention and 
outcomes (Dobkin et al. 2002).  Researchers have found functional support to play an 
important role in the prevention of premature termination (Westreich et al. 1997).  Stable 
living arrangements and involvement of a family member in the treatment episode offered 
indicators of social support in this study.  Multivariate analysis revealed that the only 
significant level of this variable was (other), this level of the living status variable refers to 
prisoners and homeless people.  This group had an odds ratio of retention 1.97 times higher 
(with a confidence interval between 1.46 and 2.67).   This is perhaps not a surprising result 
as people accessing services within prison may be more motivated for change, also 
homeless service users may have reached ‘rock bottom’, with their substance use whereby 
they are more likely to be retained in treatment.  Involvement of a family member in the 
service user’s treatment episode was shown to be a significant indicator of completion in 
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bivariate analysis but was not significant in the final model. Regarding referral source, 
previous findings have suggested a negative association between those referred through the 
criminal justice system and treatment completion (Beynon et al. 2006; Wickizer et al. 1994).  
Here the route of referral was not significantly associated with treatment drop out in the 
multivariate analysis.   
 
Bivariate analysis indicated that cannabis, hypnotic/benzo and opiates were negatively 
associated with treatment completion.  Following adjustment for other variables, primary 
use of these drugs was not found to be significant,  a result similar to that reported by 
Wickizer et al. (1994).   The separation of the dataset into observations reporting: 1) alcohol, 
and 2) illicit substances indicated that the optimal models to explain the relationship 
between the outcome and independent variables were the same for both groups.  The only 
exception was the second drug type variable which was significant for the model 
constructed for illicit drugs but not for that constructed for alcohol.  This finding is not 
surprising considering that a secondary problem substance was reported by over 60% of 
illicit drug users and only 30% of alcohol users.  This also highlights the fact that although 
treatment retention is the result of many complex factors, it does not depend specifically on 
drug of choice.   
 
The data used for this study lacked any clear indicators as to the severity of the substance 
use problem, such as the Addiction Severity Index frequently used in studies in the USA.  
The best available proxy measure was frequency of use of the primary problem substance.  
The results indicate that those using less often had a significantly higher odds of completing 
treatment.  This may be the case due to less severe addiction problems, as generally 
speaking, more frequent drug use and a higher degree of drug dependence have been 
linked to treatment dropout (Green et al. 2002; Mertens & Weisner 2000).  An alternative 
explanation of this finding is that this particular group who were using less frequently were 
generally more ready for treatment indicated by a reduction in use prior to entry.  In 
addition polysubstance use may also act as a proxy measure of problem severity.  Poly 
substance use was prevalent in the sample with more than 40% of the population reporting 
at least two problem substances.  The presence of a secondary or tertiary problem 
substance were not shown to be significant predictors of treatment completion in bivariate 
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or multivariate analysis.  Further analysis did reveal that those reporting polysubstance use 
were more likely to enter residential rather than other forms of treatment.  This may 
indicate that more complex drug usage tends to lead in the direction of residential 
treatment.  Cases whereby presence of a second problem substance was reported were 
significant and showed interesting results.  Secondary use of hypnotics, benzodiazepines 
and opiates were significantly negatively related to retention.  It was noted in the data 
description that the percentage of those reporting hypnotics/benzodiazepines as secondary 
problem substances was higher than those reporting it as a main problem substance.   
Duration of drug usage may also indicate severity of the problem, however it was not 
available in the dataset, and it is possible that initiation of use at a younger age would 
indicate a more severe problem.  However, age of first use was not shown to be related to 
the outcome in bivariate or multivariate analysis.  Duration of use may be a useful piece of 
data to collect from service users for future research.   
 
The most notable finding was with regard to treatment modality.  Residential treatment 
exhibited substantially higher completion rates relative to other forms of treatment.  
Attendees at residential treatment had completion rates of 89.5% compared to 33% for 
non-residential, 39% for low threshold and 23% for primary care and institutions.  Those 
attending residential treatment had an odds 13.5 of retention times those in other in other 
treatment settings.  This finding has been reported in many studies but attempts to 
understand this have drawn limited conclusions (Wickizer et al. 1994). It has been 
postulated that strong clinical norms and peer expectations characteristic of residential 
programmes make it more difficult to drop out of treatment prematurely.  In addition 
dropping out of other forms of treatment merely involves not presenting for a scheduled 
appointment, leaving residential treatment involves a more deliberate action (Wickizer et al. 
1994).  Further analysis revealed that those entering residential treatment were significantly 
more likely to be older, have attained higher level of education and report polysubstance 
use.  Furthermore, those reporting daily use were significantly less likely to enter residential 
treatment.  This may indicate that although those entering residential treatment have more 
complex substance use histories, they are more ready for change indicated by lower usage 
at time of entry therefore making them more likely to complete treatment.  It has also been 
put forth that the effectiveness of programs may be influenced by client characteristics, for 
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example, some clients respond more favourably to certain modalities according to Hser et 
al. (1998), indicating that an approach whereby service user is matched to treatment type 
may yield better results.   
 
Pre-screening variables through examination of Weights of Evidence (WOE) and Information 
Value (IV) proved a useful preliminary analysis tool in this study.  Five of the variables that 
were included in the final candidate models were shown to be of relative importance in 
predicting the outcome variables during pre-screening.  Although there were only fourteen 
candidate variables in this study, this practice showed that investigating variable relevance 
prior to model building is a worthwhile endeavour, particularly if there are large numbers of 
potential candidate variables, the technique offers a mechanism to discard the weakest 
predictors.  However, it should also be noted that two of the predictors which were classed 
as having no predictive power at the preliminary stage ended up in the final candidate 
models.  Therefore this method should be used with caution and not serve as an alternative 
but instead an additional measure to prior knowledge of potentially important variables, 
established through a thorough review of pertinent literature.  In addition reporting of 
results to service providers to ensure they are sensible would confirm that results are not 
just spurious.   
Bagley et al. (2001) criticized many medical studies using logistic regression for their failure 
to report validation analysis, regression diagnostics or goodness of fit measures.  One of the 
strengths of this study was outlining of the model fitting procedures in detail along with in-
depth diagnostic procedures.  In addition the use of a validation method further enhanced 
the proposed reliability of the model, an optimism corrected estimate of the c-statistic of 
0.7873 indicates that the final model has a reasonable capability of discriminating between 
the two states of a binary outcome variable.   Performing multivariate analysis based on 
variables selected through the bivariate analysis method is a commonly used procedure by 
many investigators (Sun et al. 1996). However it has been criticized because potentially 
important variables may be wrongly rejected when the relationship between the outcome 
and independent variable is confounded by another variable.  This fact was illustrated in this 
study, the second drug type variable was not significant in bivariate analysis but was found 
to be significant during the iterative model building process and in the full model fit.   
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Problems associated with the use of routine data, such as, inconsistencies in the manner in 
which information is recorded, are somewhat mitigated in this study due to the use of  
nationally agreed reporting protocols, a standardised coding framework and data validation 
checks which are performed by the Health Research Board. Furthermore, the large sample 
size increases the power of the results and reduces the likelihood of a Type II error. 
However, it should also be noted that the study relies on self-reported data and the 
accuracy of such reports cannot be verified. The standardisation of the drug treatment and 
data reporting across Ireland mean that the results from the Cork and Kerry region can be 
generalised to other areas of the country.   
 
Limitations 
The advantage of using secondary data is that it provides a ready data source to explore 
answers to interesting research questions, however one of the major limitations within this 
dataset was the lack of a unique identifier for subjects.  This effectively means that the 
system tracks treatment episodes as opposed to individuals; therefore this study was 
confined to new attendees to substance misuse treatment services to ensure that each 
individual was only entered into the study once. Had this measure not been undertaken the 
same individual could have been entered into the study several times.  Due to this 
constraint previously treated service users were not included; therefore, the data does not 
reflect the profile of all service users. If all attendees had been included, the age profile for 
example may have been older, as it is more likely that older attendees would already have 
had earlier treatment episodes.   Anecdotal information suggests that multiple prior 
admissions to substance abuse treatment indicate “bottoming out”, which should result in 
greater retention. This effect could not be captured in this study.  Yet, research results are 
mixed regarding the association between prior substance abuse treatment and retention, 
with some finding a positive relationship and some finding no relationship (Stark 1992; 
Mertens & Weisner 2000).  On the other hand this did allow for treatment modality as a 
predictor of treatment completion to be evaluated.  If re-attendees were included, it is likely 
that an individual’s entire treatment episode could be comprised of treatment within 
different modalities, rendering the inclusion of this variable impractical.  A further limitation 
of the study is the National Drug Treatment Reporting System itself. It is a difficult 
undertaking to obtain detailed information on all treatment contacts made to all treatment 
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agencies. Although close contact is maintained between the Health Research Board and all 
treatment agencies to encourage full compliance there is no way of ensuring that this 
compliance is 100%.   
 
Finally, acquisition of the data was a slow process, all treatment providers concerned had to 
be briefed on the nature of the study and provided with study protocols.   Those who were 
in agreement to giving consent for release of data pertaining to their services were 
requested to contact the Health Research Board directly.  This caused considerable delays in 
beginning analysis and limited the breadth of analysis that could be undertaken within the 
constrained time scale.  As mentioned previously there was a lack of adequate measures of 
service user addiction severity in the data, there may well have been a large variation on the 
severity of substance use problems within the study population which may account for 
retention rates.  Therefore frequency of use had to be used as a proxy measure in the 
absence of any explicit measure.    
As well as data specific limitations, several methodological limitations of this study have to 
be addressed.  Firstly interaction terms were not considered for this study.  Although there 
was detection of a possible interaction between treatment modality and second drug type, 
measures were taken to explore this and the variable was ultimately included in the final 
model.  Second drug type for example was not independently related to the outcome as 
shown in bivariate analysis.  However it only became significant once the treatment 
modality variable was entered into the model.  The decision to exclude interactions was due 
to the large number of possible interactions for fourteen predictor variables.  If all were 
examined, this would have amounted to an additional 214 potential predictors to be 
examined.   
Missing data in the study were shown to be not missing completely at random, therefore 
complete case analysis was inappropriate as it is expected to produce biased results when 
data are not MCAR  (Van Der Heijden et al. 2006).  Instead single imputation using the 
Expectation Maximisation (EM) algorithm was used for the continuous predictor and a 
constant ‘missing’, was used for categorical predictors.  The addition of another level to nine 
of the predictor created additional complexity in the variables and made interpretation of 
coefficients more difficult.  A superior method for the treatment of missing values would 
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have been multiple imputation using the Markov Chain Monte Carlo (MCMC) algorithm as it 
is more powerful than the Expectation Maximisation (EM) algorithm.  Also one of the 
shortcomings of the EM algorithm is the assumption of a parametric a priori distribution.   
Internal validation was conducted through the use of bootstrap resampling, which is the 
preferred approach for internal validation of prediction models (Steyerberg & Harrell 2015).  
However, the ultimate test for models developed on a sample dataset is to test them on 
unseen data, this would indicate if model predictions hold true for example in different 
treatment centres or for service users entering treatment more recently.  This was not 
possible within the confines of this study but it is a procedure which should be undertaken 
for future research.   
 
Impact of Findings and Orientation for Further Research 
The findings of this study illustrate the complexity of substance abuse treatment and factors 
which lead to retention or drop out.  There is a clear advantage to monitoring retention 
rates as it allows benchmarking against rates reported both nationally and internationally.  
It can also operate as marker of operational effectiveness and well as a gauge of the overall 
capacity of local services to meet the needs of the treatment population.  Service providers 
should focus on four key areas in order to increase retention rates: 
1) Establish and monitor performance against retention targets.   
2) Investigate programme level factors which may influence retention rates, such as 
counsellor to service user ratio, caseload per counsellor and provision of auxiliary support 
services.   
3) Ensure auxiliary services for family members are in place to ensure adequate social 
support is provided to the service user.   
4) Identify those with higher levels of substance usage at the earliest stage possible and take 
steps to retain them in treatment, this may require the provision of additional auxiliary 
support services or more frequent treatment contact.   
  
Clearly the environment in which treatment is received along with the various process 
measures which comprise of the entire treatment episode, have a considerable bearing on 
the outcomes.  Further research is required to investigate the link between organisational 
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level variables, such as scope of services provided, programme policies and processes, 
caseload sizes and their interrelationship with individual level factors such as those 
examined in this study.   Since the introduction of the Health Identifiers Act 2014, it is one of 
the aims of the National Drugs Strategy to put in place such a unique identifier to facilitate 
the development of reporting systems. The absence of such an identifier to date has been a 
key constraint for undertaking in-depth research of this national database as individual 
histories cannot be tracked (Connolly & Long 2014).  This development will facilitate the use 
of this rich data source as a means of answering research questions relevant to policy 
makers and service providers.   
 
Conclusion 
Despite the limitations outlined above, this study was a successful initial step in describing 
the treatment population accessing services in the Cork and Kerry region for the first time. 
Furthermore, it identified factors that are related to treatment retention, including 
treatment modality, frequency of substance use, education level, living status, secondary 
substance used and the involvement of a concerned family member in the treatment 
episode. Additionally it was highlighted that the factors leading to treatment retention were 
the same for those using alcohol or illicit substances, with the exception of higher levels of 
secondary substance use among illicit drug users.   The study also identified the significant 
differences between those entering residential treatment compared to other modalities. 
Those of older age, having higher levels of educational attainment and polysubstance users 
were more likely to enter residential treatment.   It is envisaged that these results will serve 
as a catalyst for future investigations within this treatment population as policy makers and 
service providers strive to design, implement, and evaluate treatment procedures aimed at 
improving treatment retention and outcomes. 
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Appendix 1: Study Protocols 
 
 
Study Protocols 
MSc Operational Research & Management Science 
Drug & Alcohol Services Research Project 
Introduction 
The research project to be undertaken will focus on the application of operational research 
methodologies to drug and alcohol treatment data in order to obtain insights into the 
treatment population and the factors which may lead to a service user completing 
treatment. This study has the potential to offer important insights for substance misuse 
treatment providers in the Cork and Kerry region as a collective study of this nature has not 
been undertaken, whereby statistical methods are applied to this particular dataset.  The 
group of participating service providers may include the following;  
Southern Regional Drug & Alcohol Task Force funded drug and alcohol projects (Tier 2)  
Cork Local Drug & Alcohol Task Force funded drug and alcohol projects (Tier 2) 
Health Service Executive non-residential treatment services (Tier 3) 
Matt Talbot Adolescent Services (Residential treatment Tier 4) 
Tabor Lodge Treatment Centre (Residential treatment Tier 4) 
Talbot Grove Treatment Centre (Residential treatment Tier 4) 
Cuan Mhuire, Farnannes (Residential treatment Tier 4) 
  
Aims 
 Develop an understanding of the factors which affect treatment outcomes.  
 Develop a detailed demographic profile of service users, patterns of substance use 
and how this relates to treatment outcomes.  
 Outline recommendations for strategic decision making with regard to service 
delivery aimed at increasing treatment retention.   
 
Primary Objective  
Measure treatment outcomes relative to demographic profile and substance use history of 
the substance use treatment population of Cork and Kerry between January 1st 2008 and 
December 31st 2013, in order to provide insights for treatment providers to be utilised as an 
evidence base for strategic decision making on service delivery.   
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Research Questions 
1) How does the treatment population who completed treatment in residential, non-
residential, low threshold community based and primary care/institutions in Cork and Kerry 
between January 1st 2009 and December 31st 2013 differ from those who dropped out 
prematurely during the same period based on the following variables; 
 
Demographic: Gender, Age Group  
Socio-Economic: Education Level, Employment Status, Living Status, Family Involvement  
Programme Level: Treatment Modality, Source of Referral  
Substance: Primary Substance Type, Age of First Use, Frequency of Use, Presence of Second 
Problem Substance, Second Drug Type, Presence of Tertiary Problem Substance  
 
2) What are the factors significant factors which affect treatment retention?  
 
Methods 
Data: The community drugs projects of the Cork Local & Southern Regional Drug & Alcohol 
Task Forces’ and Health Service Executive treatment services and voluntary treatment 
services feed into the National Drug Treatment Reporting System.    The National Drug 
Treatment Reporting System (NDTRS) is an epidemiological database on treated drug and 
alcohol misuse in Ireland. Data is collected on every treatment which is carried out by the 
service.  Treatment is broadly defined by the NDTRS as any activity which aims to ameliorate 
the psychological, medical or social state of individuals who seek help for their substance 
misuse problems.  
The study population will include all treated cases in Cork and Kerry from January 1st 2009 to 
December 31st 2013 who are attending the service for the first time.  Only those attending 
for the first time will be included to ensure that individuals are entered into the study only 
once.  (I.e. only data pertaining to treatments where 1 First treatment was ticked for D23 
on the NDTRS form is required) Data will be required on the following parameters, coded 
by a Health Research Board generated unique identifier for the selected cases.   
A) Administrative Details 
2a Centre Number  
2b Type  
 
B) Demographic Details 
4 Gender 
5 Age 
7a Living with whom 
7b Living Where 
11 Employment Status 
12a Age left primary or secondary school 
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12b Education: highest level completed 
 
C) Referral/Assessment Details 
14 Main reason for referral, specified main drug/problem 
15a Source of referral 
15b if client was referred from another treatment centre, please give reason for referral 
 
D) Treatment Details 
23 Type of contact with this centre (Only data relating to cases where 1 First treatment is 
ticked is required) 
 
E) Substance Use 
All data required from 24a to 28h 
 
F) Injecting Risk Behaviour  
All data required from 29a to 30  
 
G) Activity Details 
33a Treatment interventions provided  
 
H) Exit Details 
34 Outcome for main treatment intervention 
35 If outcome for main treatment intervention is premature exit from treatment site (Q34 
code 6), main reason for non-compliance 
36 Clients condition at discharge or when last seen 
39 Please specify the number of family members or significant others involved in this 
treatment 
 
Analysis: The data will be configured for uploading into R statistical analysis software.  
Exploratory data analysis will be conducted using both graphical and non-graphical 
methods.  The demographic, substance use, treatment intervention details and outcome for 
main treatment intervention will be summarised for the subject population.  Multivariate 
logistic regression analysis will be used to identify significant contributors to treatment 
outcomes for the main treatment intervention. Once significant variables are identified final 
models will be constructed.  The model building process will conclude with a series of 
goodness of fit tests and diagnostic statistics designed to identify outlying observations and 
to assess the model’s fit and performance.  Final results will be documented.   
 
Ethical Considerations  
 Participants attend addiction treatment providers voluntarily where consent is 
obtained to collect NDTRS data.  This consent also includes transfer of the data to 
the Health Research Board where it is held in a national central database and is used 
for research purposes.  Data is anonymised prior to transfer to the Health Research 
Board.   
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 Norma Madden (student) and Dr Richard Williams (supervisor) will have access to 
the data for the duration of the project from May 18th 2015 to October 31st 2015.  
 This project does not require direct access to human participants as secondary data 
will be used.  This secondary data will be anonymised prior to the student acquiring 
it, therefore human participants will not be identifiable.   
 The data will be transferred to the student through an email which will be encrypted.   
 All data and associated models will be stored on the student's laptop which will be 
encrypted using software recommended by Information Systems Services, Lancaster 
University.   
 All data will be destroyed no later than October 31st 2015.  This date has been 
chosen because it allows time for the dissertation to be graded and the student to 
receive final grades.  
 A research ethics form has been completed by the student.  This form which outlines 
the sensitivity of the data, how it will be used and who will have access to it has been 
approved by the host institution (Lancaster University).   
 The student has undertaken and passed information security training provided by 
Lancaster University.   
 A letter of agreement will be co-signed by the HSE Drug and Alcohol Services and 
Lancaster University stipulating confidentiality practices to be adhered to for the 
duration of the project.   
 
Project Timeline  
Date Event 
12th June 2015 Data Received 
15th June 2015 Data Analysis & Model Building 
7th August 2015 Dissertation Writing Begins 
11th September 2015 Submit Dissertation 
31st October 2015 All Data Destroyed 
 
Final Project Deliverable  
The final project deliverable is a dissertation submitted for MSc Operational Research and 
Management Science, Lancaster University.  
 
 
 
 
 
 
 
 
 
Lancaster University | Norma Madden 
 
64 
 
Appendix 2: Observations Removed from Dataset 
 
Clients who had the following status at the time of termination of treatment were excluded 
from the study population as failure to complete treatment was deemed to be outside of 
the clients control: 7) Released from prison but not linked to other treatment site, 8) Died, 
9) Sentenced to prison, 10) General medical transfer or medical issue, 11) No longer lives in 
the area, 12) Mental health transfer, 13) Prison to prison transfer.  This amounted to a 
further removal of 284 records.  Further preliminary analysis of the data revealed that 68 
cases indicated the primary problem substance as either “headshop drugs”, solvents, 
inhalants, antidepressants or unspecified substances.  As the number for each of these 
drugs was very low relative to the others these cases were removed.   
Appendix 3: Missing Data Analysis 
 
Missing data analysis begun with a procedure whereby the degree of ‘missingness’, in each 
variable, in each case and across the sample was measured.  Cases with missing values were 
examined in terms of their relationship to the outcome variable to ascertain if for example 
those cases had a higher percentage of either level of the outcome, or if patterns could be 
observed.  In addition data was tested to ascertain the type of ‘missingness’, by use of Little’s 
missing completely at random test.  This tests the null hypothesis that data are not missing 
completely at random.  A significant p-value therefore indicates that data are not missing 
completely at random and certain procedures for missing value treatment are not adequate.  
A significant result implies that data may be missing at random or non-ignorable missing.  The 
three types of missing values are defined as: 
Missing completely at random:  This means that special circumstances or special values in 
the data lead to higher or lower chances for missing values.  In this instance the value is not 
missing as such but is just not available in the dataset.  This may be due to accidental 
deletion or another random event whereby we cannot see the value in question.  It can 
therefore be concluded that the missing values follow the same distribution as the known 
values of the variable.   
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Missing at random:  In this case the probability for a missing value depends of the value of 
the other attributes Y but is conditionally independent of the true value of X given Y.  
Therefore the missing values of X do not follow the same distribution as the measured values 
of X.   
Non-Ignorable missing: This refers to situations where the occurrence of missing values 
directly depends on the true value, and the dependence cannot be resolved by other 
attributes.  
Appendix 4: Use of Akaike Information Criterion for Stepwise Variable 
Selection  
 
In choosing between competing models, the use of AIC would lead to the selection of the 
model with the lowest AIC.  The use of AIC was considered a superior stopping rule to P-
value as large P-values may result from collinearity indicating variables are not significant 
predictors when this may not be the case. In the forward method, an initial model is defined 
that only contains the constant (b0), each variable other than those already included is 
added to the current model, one at a time, and the one that can best improve the objective 
function, that is the AIC in this case, is retained. In the backward step, each variable already 
included is deleted from the current model, one at a time, and the one that can best 
improve the objective function is discarded. The algorithm continues until no improvement 
can be made by either the forward or the backward step.  All three methods were tried to 
allow for comparison.   
Appendix 5: Description of the Likelihood Ratio Test (LRT) 
 
The likelihood ratio test is based on the difference in deviances that is the deviance of the 
null model minus the deviance with the predictor(s) in the model.  The null model is a 
representation of when there is no relation between the predictors and the response 
variable.  It is an intercept only model where the data is represented entirely as random 
variation.   
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Appendix 6: Description of Hosmer Lemeshow Goodness of Fit Test  
 
First, the observations are sorted in increasing order of their estimated event probability.   
The observations are then divided into G groups. The Hosmer-Lemeshow goodness-of-fit 
statistic is obtained by calculating the Pearson chi-square statistic from the 2×G table of 
observed and expected frequencies, for the G groups. The distribution of the statistic is 
approximated by a chi-square with (G-2) degrees of freedom (Hosmer & Lemeshow 2000).   
Appendix 7: Description of the C-Statistic  
 
When outcomes are binary, the c-statistic is the probability that a randomly selected subject 
who completed treatment has a higher predicted probability of completing treatment than 
a randomly selected subject who did not complete treatment. C-statistic or AUC values 
range from 50 percent which is the case where the model does not have the power to 
accurately discriminate cases those who complete treatment and those who do not, above 
and beyond a 50/50 random chance to 100 percent, which is the idealised situation where 
the model achieves perfect discrimination between completed and not completed.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Lancaster University | Norma Madden 
 
67 
 
Appendix 8: Logistic Regression Results Model 3 
 
Table 12: Final Results of Logistic Regression Analysis – Model 3 
 
 
 
 
 
 
 
 
 
 
 
Parameter Estimate
Standard 
Error
Wald chi-
square Pr>ChiSq
Odds 
ratio  (Conf. Int)
Intercept 0.4448 0.3675 1.21 0.2261 1.56 (0.76, 3.21)
Living Alone -0.2053 0.1348 -1.52 0.1278 0.81 (0.62, 1.06)
Partner/Friends -0.1365 0.1404 -0.97 0.331 0.87 (0.66, 1,15)
Parents/Family -0.0275 0.1069 -0.26 0.7974 0.97 (0.79, 1.2)
Other 0.6637 0.1538 4.32 0 1.94 (1.44, 2.63)
Missing 0.0413 0.3703 0.11 0.9112 1.04 (0.49, 2.13)
Children/partner reference
Education Level Primary or less -0.957 0.1435 -6.67 0 0.38 (0.29, 0.51)
Second Level (J) -0.5916 0.1147 -5.16 0 0.55 (0.44, 0.69)
Second Level (L) -0.5181 0.1186 -4.37 0 0.6 (0.47, 0.75)
Third Level -0.1627 0.1869 -0.87 0.3841 0.85 (0.59, 1.23)
Missing -0.6492 0.1452 -4.47 0 0.52 (0.39, 0.69)
Current reference
Treatment Modality Residential 2.5667 0.1449 17.72 0 13.02 (9.84, 17.36)
Non-residential -0.2118 0.0941 -2.25 0.0244 0.81 (0.67, 0.97)
PrimC/Institution -0.6745 0.2076 -3.25 0.0012 0.51 (0.34, 0.76)
Low threshold reference
Frequency of Use Daily -0.1096 0.092 -1.19 0.2336 0.9 (0.75, 1.07)
Weekly or less 0.3129 0.1124 2.78 0.0054 1.37 (1.1, 1.7)
No use past month 0.6802 0.1066 6.38 0 1.97 (1.6, 2.43)
Missing -0.3139 0.3462 -0.91 0.3645 0.73 (0.36, 1.42)
2 to 6 days p/w reference
Second Drug Type Cannabis -0.1912 0.1349 -1.42 0.1566 0.83 (0.63, 1.08)
Hypnotic/Benzo -0.6756 0.2026 -3.34 0.0009 0.51 (0.34, 0.75)
No Drug -0.0527 0.1121 -0.47 0.6384 0.95 (0.76, 1.18)
Opiate -1.0772 0.4449 -2.42 0.0155 0.34 (0.14, 0.8)
Other -0.2911 0.2689 -1.08 0.2789 0.75 (0.44, 1.26)
Stimulant -0.4153 0.1847 -2.25 0.0245 0.66 (0.46, 0.95)
Alcohol reference
CP Involved Yes -0.0948 0.331 -0.29 0.7747 0.91 (0.48, 1.75)
No -0.7274 0.3307 -2.2 0.0278 0.48 (0.25, 0.93)
Missing reference
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Appendix 9: Logistic Regression Results Model 3 (Influential 
Observations Removed) 
 
Table 13: Logistic Regression Results – Model 3 (Influential Observations Removed) 
 
 
 
 
 
 
 
 
 
 
 
Parameter Estimate
Standard 
Error
Wald chi-
square Pr>ChiSq
Odds 
ratio  (Conf. Int)
Intercept 0.3267 0.3768 0.87 0.3859 1.39 (0.66, 2.9)
Living Alone -0.2005 0.1354 -1.48 0.1386 0.82 (0.63, 1.07)
Partner/Friends -0.1255 0.1409 -0.89 0.3731 0.88 (0.67, 1.16)
Parents/Family -0.0084 0.1075 -0.08 0.9375 0.99 (0.8, 1.22)
Other 0.6778 0.1545 4.39 0 1.97 (1.46, 2.67)
Missing -0.004 0.3894 -0.01 0.9918 1 (0.45, 2.11)
Children/partner reference
Education Level Primary or less -0.9445 0.144 -6.56 0 0.39 (0.29, 0.51)
Second Level (J) -0.5774 0.115 -5.02 0 0.56 (0.45, 0.7)
Second Level (L) -0.5092 0.119 -4.28 0 0.6 (0.48, 0.76)
Third Level -0.13 0.1878 -0.69 0.4888 0.88 (0.61, 1.27)
Missing -0.634 0.1458 -4.35 0 0.53 (0.4, 0.71)
Current reference
Treatment Modality Residential 2.6059 0.1464 17.8 0 13.54 (10.2, 18.11)
Non-residential -0.214 0.0944 -2.27 0.0233 0.81 (0.67, 0.97)
PrimC/Institution -0.7022 0.2095 -3.35 0.0008 0.5 (0.33, 0.74)
Low threshold reference
Frequency of Use Daily -0.1081 0.0924 -1.17 0.2422 0.9 (0.75, 1.08)
Weekly or less 0.3275 0.1127 2.91 0.0037 1.39 (1.11, 1.73)
No use past month 0.6929 0.107 6.47 0 2 (1.62, 2.47)
Missing -0.3541 0.3569 -0.99 0.3211 0.7 (0.34, 1.39)
2 to 6 days p/w reference
Second Drug Type Cannabis -0.2055 0.1354 -1.52 0.1292 0.81 (0.62, 1.06)
Hypnotic/Benzo -0.6923 0.2036 -3.4 0.0007 0.5 (0.33, 0.74)
No Drug -0.057 0.1124 -0.51 0.6118 0.94 (0.76, 1.18)
Opiate -1.4371 0.4678 -3.07 0.0021 0.24 (0.09, 0.59)
Other -0.3536 0.2722 -1.3 0.1938 0.7 (0.41, 1.19)
Stimulant -0.4336 0.1856 -2.34 0.0195 0.65 (0.45, 0.93)
Alcohol reference
CP Involved Yes 0.0106 0.3413 0.03 0.9753 1.01 (0.52, 1.99)
No -0.6324 0.341 -1.85 0.0637 0.53 (0.27, 1.05)
Missing reference
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Table 14: Logistic Regression Results (Dependent Variable – Treatment Modality) 
 
 
Parameter Estimate
Standard 
Error
Wald chi-
square Pr>ChiSq
Odds 
ratio  (Conf. Int)
Intercept -1.7847 0.2182 -8.18 0 0.17 (0.11, 0.25)
Age Range under 20 -1.9175 0.1863 -10.29 0 0.15 (0.1, 0.21)
30 to 39 0.2984 0.1124 2.65 0.008 1.35 (1.08, 1.68)
40 and over 0.9589 0.1106 8.67 0 2.61 (2.1, 3.24)
20 to 29 Reference
Education Level Primary or less 0.1102 0.2314 0.48 0.6339 1.12 (0.71, 1.77)
Second Level (J) 0.3409 0.2124 1.61 0.1085 1.41 (0.94, 2.15)
Second Level (L) 0.9432 0.2104 4.48 0 2.57 (1.72, 3.92)
Third Level 1.1264 0.241 4.67 0 3.08 (1.94, 4.99)
Missing -0.9193 0.2722 -3.38 0.0007 0.4 (0.23, 0.68)
Current Reference
Primary Substance Cannabis -0.4899 0.1351 -3.63 0.0003 0.61 (0.47, 0.8)
Hypno/Benzo -0.7722 0.234 -3.3 0.001 0.46 (0.29, 0.72)
Opiate -0.7298 0.1822 -4.01 0.0001 0.48 (0.33, 0.68)
Stimulant -0.6872 0.218 -3.15 0.0016 0.5 (0.32, 0.76)
Alcohol Reference
Frequency of Use Daily -0.3709 0.1082 -3.43 0.0006 0.69 (0.56, 0.85)
Weekly or less -0.1921 0.1315 -1.46 0.144 0.83 (0.64, 1.07)
No use past month -0.2148 0.1116 -1.93 0.0542 0.81 (0.65, 1)
Missing 0.4005 0.3841 1.04 0.297 1.49 (0.68, 3.11)
2 to 6 days p/w Reference
Secondary Drug Use Yes 0.5026 0.1147 4.38 0 1.65 (1.32, 2.07)
No Reference
Tertiary Drug Use Yes 0.857 0.1277 6.71 0 2.36 (1.84, 3.03)
No Reference
